PATIENT-REPORTED VARIABLES ASSOCIATED WITH THE SUCCESS OF BEHAVIORAL INTERVENTION FOR PATIENTS WITH CHRONIC COUGH by Loomis, Bridget
University of Montana 
ScholarWorks at University of Montana 
Graduate Student Theses, Dissertations, & 
Professional Papers Graduate School 
2016 
PATIENT-REPORTED VARIABLES ASSOCIATED WITH THE 
SUCCESS OF BEHAVIORAL INTERVENTION FOR PATIENTS WITH 
CHRONIC COUGH 
Bridget Loomis 
Follow this and additional works at: https://scholarworks.umt.edu/etd 
 Part of the Allergy and Immunology Commons, Family Medicine Commons, Medical Education 
Commons, Otolaryngology Commons, Primary Care Commons, Pulmonology Commons, Rehabilitation 
and Therapy Commons, Speech Pathology and Audiology Commons, and the Sports Medicine Commons 
Let us know how access to this document benefits you. 
Recommended Citation 
Loomis, Bridget, "PATIENT-REPORTED VARIABLES ASSOCIATED WITH THE SUCCESS OF BEHAVIORAL 
INTERVENTION FOR PATIENTS WITH CHRONIC COUGH" (2016). Graduate Student Theses, Dissertations, 
& Professional Papers. 10726. 
https://scholarworks.umt.edu/etd/10726 
This Thesis is brought to you for free and open access by the Graduate School at ScholarWorks at University of 
Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an 
authorized administrator of ScholarWorks at University of Montana. For more information, please contact 
scholarworks@mso.umt.edu. 
Running	head:	VARIABLES	ASSOCIATED	WITH	THE	SUCCESS	OF	BCT	
PATIENT-REPORTED	VARIABLES	ASSOCIATED	WITH	THE	SUCCESS	OF	BEHAVIORAL	
INTERVENTION	FOR	PATIENTS	WITH	CHRONIC	COUGH	
	
By	
	 	
Bridget	Kathleen	Loomis	
Bachelor	of	Arts,	Montana	State	University,	Bozeman,	Montana,	2010	
	
	
Thesis	Paper	
	
presented	in	partial	fulfillment	of	the	requirements	for	the	degree	of	
	
Master	of	Science	
in	Speech-Language	Pathology	
	
The	University	of	Montana	
Missoula,	MT	
May,	2016	
	
Approved	by:	
Laurie	Slovarp,	Ph.D.,	CCC-SLP,	Chair	
Communicative	Sciences	and	Disorders	
Amy	Glaspey,	Ph.D.,	CCC-SLP	
Communicative	Sciences	and	Disorders	
Daniel	Lee,	Ed.D.		
Educational	Leadership	
	 	
VARIABLES	ASSOCIATED	WITH	THE	SUCCESS	OF	BCT	 ii	
Abstract	
Purpose:	To	determine	if	patient-related	variables	exist	that	can	potentially	discriminate	
patients	with	refractory	chronic	cough	(RCC)	that	are	reasonable	candidates	for	behavioral	
cough	therapy	(BCT).	This	study	was	a	small	sub-set	of	a	larger,	ongoing	study,	which	aims	to	
create	a	screening	tool	that	can	identify	refer	patients	who	are	candidates	for	BCT.	
Methods:	In	this	prospective,	exploratory	study,	20	adult	participants,	aged	29-68	years	of	age,	
answered	questions	developed	by	an	expert	panel,	and	the	Leicester	Cough	Questionnaire	
(LCQ),	before	and	after	BCT.	Questions	pertained	to	symptoms,	personality	characteristics,	and	
cough	triggers.	Data	were	gathered	using	Qualtrics	survey	software.	Participants	were	
separated	into	groups	following	data	collection	according	to	their	satisfaction	with	BCT.	
Results:	Twelve	participants	were	satisfied	with	the	status	of	their	cough	(BCT-S)	and	eight	
participants	were	not	satisfied	(BCT-NS).	Non-parametric	statistical	analyses	revealed	significant	
differences	between	the	groups	on	the	following	variables:	difficulty	breathing	in,	urge	to	
throat	clear,	productivity	of	cough,	perceiving	reflux/heartburn,	blocked-throat	feeling,	
anxiousness,	and	stress	in	neck/shoulders.	LCQ	domain	scores	were	also	significantly	different.	
Conclusion:	The	current	study	provides	preliminary	evidence	that	suggests	there	are	
differences	in	patient-reported	variables	associated	with	success	of	BCT.	These	results	indicate	
the	potential	to	create	and	validate	a	screening	tool	that	would	assist	with	identification	of	
candidates	for	BCT.			
Key	words:	chronic	cough,	behavioral	cough	therapy,	Leicester	Cough	Questionnaire,	laryngeal	
hypersensitivity,	speech-language	pathology,	cough	suppression,	nonpharmacological	
intervention	 	
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Chapter	1:	Introduction	and	Literature	Review	
	 Chronic	cough	(CC)	is	defined	as	a	cough	lasting	for	more	than	eight	weeks	and	it	is	the	
most	common	reason	for	an	adult	to	consult	a	primary	physician	for	medical	treatment	(French,	
Irwin,	Curley,	&	Krikorian,	1998;	Iyer	&	Lim,	2013;	Natt,	Earis,	&	Swift,	2012).	While	the	exact	
prevalence	of	CC	is	difficult	to	estimate,	up	to	40%	of	the	population	report	suffering	from	CC	
(Chung	&	Pavord,	2008;	Morice	et	al.,	2004;	Morice	&	Kastelik,	2003).	CC	can	have	many	
contributing	etiologies,	most	of	which	can	successfully	be	treated	via	medical	intervention	
(Gibson	&	Vertigan,	2008;	Vertigan,	Theodoros,	Gibson,	&	Winkworth,	2007a).	However,	12-
42%	of	patients	who	seek	medical	treatment	continue	to	have	what	is	known	as	refractory,	
habit,	psychogenic,	idiopathic,	or	unexplained	chronic	cough	(Chamberlain,	Birring,	&	Garrod,	
2014;	Vertigan,	Theodoros,	Winkworth,	&	Gibson,	2007b).	For	the	purpose	of	this	study,	we	will	
use	the	term	refractory	chronic	cough	(RCC)	in	order	to	encompass	the	unresolved	nature	of	
the	cough	(Birring,	2001;	Gibson	&	Vertigan,	2009;	Morice,	2010;	Morice,	2013;	Ryan,	Vertigan,	
Bone,	&	Gibson,	2010;	Vertigan,	Gibson,	Theodoros,	&	Winkworth,	2008).	
RCC	is	a	complex	disorder	that	has	significant	health,	psychological,	and	financial	
repercussions.	RCC	generally	presents	following	an	upper	respiratory	infection	(URI)	that	
includes	a	severe	cough.	Although	the	URI	resolves,	the	cough	persists	(Gibson	&	Vertigan,	
2009).		It	is	most	prevalent	in	middle-aged	females	(Chamberlain	et	al.,	2013;	Iyer	&	Lim,	2013).	
The	duration	of	RCC	in	patients	has	been	documented	to	last	as	little	as	a	few	months	to	as	long	
as	twenty	years	(Vertigan	et	al.,	2007).	Research	documents	a	relationship	between	patients	
with	RCC	and	anxiety,	frustration,	and/or	depression	(Iyer	&	Lim,	2013;	Natt	et	al.,	2012).	
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Patients	with	RCC	also	commonly	have	co-occurring	laryngeal	problems	such	as	vocal	cord	
dysfunction	(VCD)	and	muscle	tension	dysphonia	(Vertigan	et	al.,	2007a;	Vertigan	et	al.,	2008).		
	 The	current	management	model	for	patients	with	chronic	cough	is	laborious,	expensive,	
and	inefficient	for	many	patients	(Morice,	2013;	Pavord	&	Chung,	2008).	Traditionally,	the	
recommended	management	model	for	RCC	has	either	been	to	“test	all,	then	treat,”	which	is	
expensive	and	time	consuming,	or	treat	any	likely	contributor	to	the	cough	one	at	a	time,	which	
is	often	unremitting	(Iyer	&	Lim,	2013;	Morice	et	al.,	2004).	Furthermore,	the	numerous	tests	
that	a	patient	may	undergo	can	cost	thousands	of	dollars,	not	to	mention	the	cost	of	
medication	and	lost	wages.		However,	behavioral	cough	therapy	(BCT)	offers	an	alternative	to	
these	treatment	approaches	and	a	corpus	of	research	is	growing	to	support	its	efficacy,	
efficiency,	and	cost	effectiveness.		
BCT	is	a	simple,	non-invasive	treatment,	typically	provided	by	speech-language	
pathologists	(SLPs).	Four	general	components	compose	BCT	therapy:	education,	cough	
suppression,	vocal	hygiene,	and	counseling	(Chamberlain	et	al,	2013;	Gibson	&	Vertigan,	2009;	
Vertigan	et	al.,	2007a).		Existing	studies	show	that	patients	who	benefit	from	BCT	exhibit	
alleviation	of	cough	symptoms	in	as	little	as	two	weeks	(Chamberlain	et	al.,	2013,	Gibson	&	
Vertigan,	2009;	Ryan	et	al.,	2010;	Vertigan	et	al.,	2007a;	Vertigan	et	al.,	2007),	which	would	
likely	only	cost	the	patient	a	few	hundred	dollars.	By	comparison,	the	current	medical	model	of	
treatment	often	costs	up	to	several	thousand	dollars	(Lin,	Poh,	&	Lim,	2001).	Additionally,	
patients	with	RCC	wait	on	average	18-60	months	before	being	referred	for	BCT,	and	many	
patients	are	not	referred	at	all	(Chamberlain	et	al.,	2013).	
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Statement	of	the	Problem	
	 The	current	recommended	algorithm	for	treating	CC	is	time-consuming	and	expensive	
for	patients	with	RCC.	Behavioral	cough	therapy	(BCT)	is	rarely	considered	as	an	early	option	for	
the	treatment	of	CC,	yet	it	has	been	shown	to	be	safe,	effective,	efficient,	and	inexpensive	for	
many	patients	(Chamberlain	et	al.,	2013;	Ryan	et	al.,	2010;	Vertigan,	Theodoros,	Gibson,	&	
Winkworth,	2006).	A	validated	screening	tool	is	needed	to	assist	primary	care	providers	in	
identifying	patients	who	are	good	candidates	for	BCT	immediately	after	ruling	out	the	most	
common	and	most	serious	causes	of	cough.	The	first	step	for	developing	a	screening	tool	is	to	
investigate	the	traits	of	patients	who	are	satisfied	with	the	effects	of	BCT.	
Purpose	 	
The	purpose	of	this	study	was	to	determine	if	patient-related	variables	exist	that	have	
the	potential	to	discriminate	patients	with	RCC	that	are	reasonable	candidates	for	BCT.	
Potential	variables	for	analysis	included	symptoms,	onset	factors	(e.g.,	cough	persisting	after	an	
illness	with	significant	coughing),	response	to	prior	treatment,	co-occurring	diagnoses,	cough	
triggers,	and	personality	traits.	Determination	of	variables	that	discriminate	between	patients	
who	are	or	are	not	satisfied	with	BCT	will	assist	in	the	development	of	a	validated	screening	
tool	to	be	used	early	in	the	management	process.	
Research	Question	and	Hypothesis	
This	study	addressed	the	following	primary	research	question:	
1. Is	there	a	difference	in	patient-reported	variables	in	patients	with	RCC	who	are	satisfied	
with	BCT	and	patients	with	RCC	who	are	not	satisfied	BCT?		
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a. Null	 hypothesis:	 There	 are	 no	 patient-reported	 variables	 that	 are	 different	
between	 patients	 with	 RCC	who	 are	 satisfied	with	 BCT	 and	 patients	 with	 RCC	
who	are	not	satisfied	with	BCT.		
b. Alternative	hypothesis:	There	are	patient-reported	variables	that	differ	between	
patients	with	 RCC	who	 are	 satisfied	with	 BCT	 and	 those	who	 are	 not	 satisfied	
with	BCT.		
If	the	alternative	hypothesis	for	research	question	#1	is	confirmed,	the	following	sub	question	
will	be	asked:	
2. If	 differences	 are	 evident	 between	 patients	with	 RCC	who	 are	 satisfied	with	 BCT	 and	
those	who	are	not,	what	variables	are	different?			
a. Alternative	hypothesis	1:	Patients	who	are	satisfied	with	BCT	are	hypothesized	to	
report	the	following	differences	from	patients	who	are	not	satisfied	with	BCT:	
• More	difficulty	breathing	in	than	out;	
• A	less	or	non-productive	cough;	
• More	of	a	tickling/itching	feeling	in	their	throat;	
• Onset	 of	 their	 cough	 began	 with	 an	 illness	 that	 involved	 significant	
coughing;	and	
• Higher	occurrence	of	the	following	cough	triggers:	strong	smells,	changes	
in	air	temperature,	exercise,	stress/anxiety,	and	smoke	
b. Alternative	 hypothesis	 2:	 Patients	who	 are	 satisfied	with	 BCT	will	 report	more	
“Type	A”	personality	qualities	 (e.g.,	high-achieving,	 competitive,	 stressed,	need	
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to	 be	 in	 control,	 etc.)	 than	 those	 who	 are	 not	 satisfied	 with	 BCT	 (Watson	 &	
Minzenmayer,	2006).		
Literature	Review	
Chronic	cough	is	challenging	to	diagnose	and	treat	and	is	caused	by	numerous	
conditions,	including	smoking,	post-nasal	drip,	asthma,	reflux,	and	unknown	causes	(McGarvey	
&	Morice,	2005).	While	many	patients	with	CC	may	present	with	any	of	these	etiologies,	the	
term	refractory	chronic	cough	(RCC)	is	prescribed	when	all	known	causes	have	either	been	
ruled	out	or	treatment	has	failed	(Chamberlain	et	al.,	2013;	Vertigan	et	al.,	2007a).	McGarvey	
(2013)	reported	that	inadequate	evaluation,	patient	non-compliance,	and	side	effects/safety	
concerns	contribute	to	the	difficulty	of	treating	RCC.	However,	the	systematic	approach	to	
treating	patients	with	RCC,	in	addition	to	treatment	barriers,	is	a	time-consuming	and	expensive	
process.	Current	practice	implements	an	extensive	process	of	elimination	to	determine	the	
causes	of	and	treat	the	cough,	which	may	be	costly	and	time-intensive	and	may	have	negative	
impacts	on	the	patient’s	quality	of	life	(QoL).	Effects	on	QoL	may	include	symptoms	such	as	
depression	and	lethargy	in	addition	to	their	cough	symptoms	(Brignall,	Jayarman,	&	Birring,	
2008;	Chamberlain,	Garrod,	&	Birring,	2013;	Chung,	2011).	Further,	cough-related	symptoms	
can	include	sleep	deprivation,	incontinence,	or	even	vomiting,	which	can	further	decrease	QoL	
in	this	population	(Brignall	et	al.,	2008).		
	 Many	common	symptoms	and	triggers	are	evident	among	patients	with	RCC.	Common	
symptoms	include	a	persistent	tickling	feeling	in	the	throat,	an	irritating	sensation,	a	sensation	
of	choking,	and	the	urge	to	throat	clear	or	cough	(Chung,	2011;	Gibson	&	Vertigan,	2009;	Ryan	
et	al.,	2010;	Vertigan	et	al.,	2007).	These	symptoms	are	most	commonly	triggered	by		smoke,	
VARIABLES	ASSOCIATED	WITH	THE	SUCCESS	OF	BCT	 6	
dry	crumbly	foods,	strong	fumes,	perfumes,	dramatic	change	in	air	temperature	or	humidity,	
exercise,	stress,	or	talking	(Vertigan	&	Gibson,	2010;	Vertigan	et	al.,	2007;	Vertigan,	Theodoros,	
Gibson,	&	Winkworth,	2007b).	Patients	frequently	describe	their	cough	as	dry,	barking,	and	self-
propagating	(Vertigan	et	al.,	2007b).Many	also	complain	of	voice	problems	(Gibson	&	Vertigan,	
2009;	Ryan,	Vertigan,	&	Gibson,	2009).		
The	most	common	concomitant	voice	issues	include	muscle	tension	dysphonia	(MTD)1	
and	paradoxical	vocal	fold	movement	(PVFM)2;	(Chamberlain	et	al.,	2014;	Gibson	&	Vertigan,	
2009;	Vertigan	et	al.,	2007b).	Symptoms	of	MTD	and	PVFM	are	often	exacerbated	by	stress	and	
anxiety	(Dietrich,	Abbott,	Gartner-Schmidt,	&	Rosen,	2006;	Hui	Ng,	Lo,	Lim,	Goh,	&	
Kanagalingam,	2013).	Additionally,	patients	with	MTD	and/or	PVFM	frequently	exhibit	“Type	A”	
personality	traits3,	anxiety,	and	stress	(Dietrich	et	al.,	2006;	Hui	Ng	et	al.,	2013).	Therefore,	
because	of	the	relationship	between	RCC	and	MTD	and	PVFM,	it	is	possible	that	patients	with	
RCC	may	exhibit	more	“Type	A”	personality	traits,	stress,	and	anxiety	as	well.	
	 Anatomy	and	Physiology	of	Laryngeal	Hypersensitivity	and	the	Cough	Reflex.	The	
mechanisms	that	result	in	RCC	involve	a	complex	neural	network	that	is	not	fully	understood	
(Mazzone,	Cole,	Ando,	Egan,	&	Farrell,	2011;	Morice,	2013;	Spina	&	Page,	2013).	The	cough	
reflex	involves	cough	receptors,	afferent	(sensory)	pathways,	central	processing,	and	efferent	
(motor)	pathways	(Bucca	et	al.,	2010;	McGarvey,	2005).	When	a	cough	is	triggered,	sensory	
receptors	in	the	upper	airway	respond	to	a	stimuli	and	send	the	information	up	the	vagus	nerve	
																																																						
1	Hui	Ng	et	al.,	(2013)	define	MTD	as	a	functional	voice	disorder	meaning	it	has	no	organic	pathology		
2	Ryan	et	al.,	(2009)	define	PVFM	as	the	vocal	folds	paradoxically	adducting	instead	of	abducting	on	inhalation	
3	Hui	Ng	et	al.,	(2013)	and	Watson	&	Minzenmayer	(2006)	describe	“Type	A”	personality	traits	as	being	time	
conscious,	aggressive,	controlling,	ambitious,	impatient,	and	competitive	
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to	the	nucleus	tractus	solitarius	in	the	brainstem	(Chung	&	Pavord,	2008).	Once	the	information	
is	decoded	in	the	brainstem,	efferent	messages	are	sent	to	the	respiratory	and	laryngeal	
muscles	resulting	in	a	cough	(Chung	&	Pavord,	2008).	
	In	patients	with	RCC,	research	suggests	that	the	cough’s	underlying	mechanism	is	a	
hypersensitization	of	afferent	vagal	receptors	in	the	larynx	(Chung,	2011;	Morice,	2010;	Morice,	
2013;	Spina	&	Page,	2013).		Under	normal	circumstances,	chemical	and	mechanical	irritants	
(i.e.,	stimuli)	that	are	potentially	harmful	to	the	lungs	trigger	a	response	in	the	vagus	nerve	
receptors	that	are	delivered	to	the	cough	center	in	the	brainstem	(Mazzone,	et	al.,	2011;	
Vertigan	et	al.,	2008).	In	patients	with	RCC,	afferent	receptors	in	the	larynx	are	hypersensitive	
to	non-noxious	environmental	stimuli	such	as	a	change	in	room	temperature,	perfumes,	or	
cleaning	agents	(Morice,	2013).	Research	also	indicates	that	coughing	itself	creates	a	“feed	
forward	system”	that	perpetuates	the	cough	by	further	enhancing	the	sensory	mechanisms,	
which	means	that	constant	coughing	contributes	to	the	continued	lowering	of	the	cough	
threshold	(Chung,	2011).	Subsequently,	the	cough	reflex	is	triggered	by	a	lower	level	of	stimuli	
(Vertigan	et	al.,	2007a).	Based	on	principles	of	neuroplasticity,	the	laryngeal	cells	themselves	
then	change	how	they	react	to	incoming	stimuli	after	prolonged	exposure	to	stimuli	(McGarvey,	
2005;	McGarvey	&	Morice,	2005;	Vertigan	et	al.,	2008).		
	While	the	cough	reflex	is	housed	in	the	brainstem,	and	is	generally	thought	to	be	a	
reflexive	action,	emerging	evidence	suggests	that	cough	may	involve	a	“top	down”	directive	
from	cortical	brain	structures	(Mazzone	et	al.,	2011;	Vertigan	et	al.,	2008).	Mazzone	and	
colleagues	(2011)	supported	this	hypothesis	by	measuring	blood	oxygen	level-dependent	
(BOLD)	responses	with	functional	magnetic	resonance	imaging	(fMRI).	They	found	that	the	
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supplementary	motor	cortex	(SMC)	was	activated	during	voluntary	cough	and	cough	
suppression.	However,	the	SMC	was	inactive	in	a	chemically	induced	reflexive	cough.	Similar	
brain	activations	are	evident	during	voluntary	breath	holding,	which	lends	support	to	the	
intertwined	relationship	between	respiration	and	cough	suppression,	both	of	which	are	
addressed	with	BCT.		
	Cortical	influence	on	cough	supports	research	of	medical	treatments.	Studies	assessing	
peripheral	(i.e.,	laryngeal)	hypersensitivity	sometimes	use	antitussive	medication	as	a	control	
because	antitussives	act	on	the	central	nervous	system	to	suppress	a	cough	(McGarvey,	2013;	
McGarvey	&	Morice,	2005).	However,	because	antitussives	have	little	effect	on	reducing	
laryngeal	sensitivity,	some	element	of	cortical	control	of	cough	is	evident	(Chamberlain	et	al.	
2013).	The	potential	central	mechanisms	involved	in	RCC	also	explain	the	abnormal	sensations	
experienced	by	patients	(e.g.,	tickling	sensation),	similar	to	patients	with	other	hypersensitivity	
conditions,	such	as	chronic	pain	(Chamberlain	et	al.,	2014).	Moreover,	partial	cortical	control	of	
cough	explains	why	medications	(e.g.,	gabapentin)	that	are	effective	for	processes	controlled	by	
the	central	nervous	system	have	shown	some	success	in	abating	RCC	(Ryan	&	Gibson,	2014).		
Some	of	the	structures	and	pathways	associated	with	chronic	cough	overlap	with	those	
associated	with	chronic	pain	(Chamberlain	et	al.,	2013;	Gibson,	Simpson,	Ryan,	&	Vertigan,	
2014;	Mazzone	et	al.,	2011).	Chronic	cough	and	chronic	pain	both	protect	the	human	body	from	
noxious	stimuli	through	similar	pathways	(O’Neill,	McMahon,	&	Undem,	2013).	Similarly,	the	
sensory	neurons	in	both	conditions	can	become	hypersensitive,	resulting	in	conditions	such	as	
hyperalgesia	(O’Neill	et	al.,	2013).	A	behavioral	approach,	cognitive	behavioral	therapy	(CBT)	
has	been	effective	for	alleviating	chronic	pain	(e.g.,	back	pain	or	arthritis)	and	pain-related	
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depression	as	well	as	improving	health-related	quality	of	life	(Ehde,	Dillworth,	&	Turner,	2014).	
Understanding	the	relationship	between	chronic	cough	and	chronic	pain	may	strengthen	the	
limited	research	on	chronic	cough	and	its	underlying	laryngeal	hypersensitivity	by	
encompassing	the	plethora	of	research	on	chronic	pain	(O’Neill	et	al.,	2013).		
The	extent	of	the	underlying	laryngeal	sensitivity	in	chronic	cough	that	provides	crucial	
information	can	be	objectively	measured	in	a	few	different	ways.	For	example,	cough	frequency	
may	be	measured	in	response	to	pre-determined	amounts	of	inhaled	capsaicin	or	citric	acid	
(Morice	et	al.,	2004).	Capsaicin	is	the	spicy	component	in	hot	peppers	and	has	been	reliably	
tested	and	used	to	measure	cough	threshold	(Morice	et	al.,	2004).		Morice	et	al.	(2001)	
describe	the	two	main	ways	a	capsaicin	challenge	is	conducted:	single	dose	or	dose	response.	In	
single	dose,	the	patient	inhales	one	measured	dose	of	capsaicin	and	the	number	of	coughs	is	
recorded.	Dose	response	involves	multiple	inhalations	of	measured	doses	to	find	the	dose	that	
elicits	a	certain	number	of	coughs	(Morice	et	al.,	2001;	Pavord	&	Chung,	2008).	
The	capsaicin	challenge	has	been	used	to	demonstrate	heightened	laryngeal	sensitivity	
in	patients	with	RCC.	Ryan	et	al.	(2009)	had	their	participants	inhale	controlled	dosages	of	
increasing	concentrations	of	capsaicin.	The	subject	hit	threshold	when	they	either	coughed	five	
or	more	times	or	tolerated	a	dose	of	the	most	potent	concentration.	They	found	that	both	
patients	with	RCC	alone	and	with	RCC	in	addition	to	paradoxical	vocal	fold	movement	(PVFM)	
significantly	increased	their	tolerance	to	capsaicin	exposure	following	BCT.	Ryan	et	al.,	(2010)	
also	noted	that	compared	with	normed	scores,	patients	in	their	study	had	heightened	
sensitivity	to	capsaicin	at	baseline	that	significantly	improved	with	BCT.		
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Assessment	and	Treatment	of	Cough.	In	the	assessment	of	cough,	a	methodical,	
medical	approach	is	typically	used	to	eliminate	or	identify	causes	of	cough	that	is	based	on	an	
“anatomic	diagnostic	protocol”	developed	by	Irwin	and	colleagues	in	1981	(Irwin,	Corrao,	&	
Pratter,	1981;	MacGarvey,	2013;	Pavord	&	Chung,	2008;	Vertigan	et	al.,	2007).		The	“anatomic	
diagnostic	protocol”	is	a	systematic	way	to	conduct	an	evaluation	and	determine	the	cause	of	a	
persistent	cough	(Irwin	et	al.,	1981).		This	protocol	emphasizes	the	importance	of	how	different	
conditions	affect	anatomical	structures,	such	as	the	hypersensitization	of	the	laryngeal	sensory	
receptors	(Pavord	&	Chung,	2008).	During	the	evaluation,	a	comprehensive	history	is	necessary	
to	exclude	personal	(e.g.,	smoking),	occupational	(e.g.,	factory	workers),	or	iatrogenic	(e.g.,	
angiotensin	converting	enzyme,	or	ACE-inhibitors)	causes	for	the	cough	(Lee	&	Birring,	2012;	
Morice	et	al.,	2004;	Natt	et	al.,	2012).	Further	examination	includes	a	chest	x-ray	and	possibly	
spirometry	to	rule	out	underlying	respiratory	conditions	(Lee	&	Birring,	2012).	If	these	tests	are	
negative,	the	most	common	approach	is	to	medically	treat	without	testing	for	the	most	
common	causes	of	chronic	cough	(i.e.,	reflux,	asthma,	and	post-nasal	drip)	(Lee	&	Birring,	2012).	
See	Figure	1,	developed	by	Morice	and	committee	members	in	2004,	for	an	overview	of	the	
typical	management	algorithm	for	chronic	cough.			
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	Figure	1	Management	of	chronic	cough:	Reprinted	from	Morice	et	al.,	2004	
	
When	respiratory	causes,	aggravating	factors	(e.g.,	reflux,	post-nasal	drip,	asthma),	and	
personal	factors	are	ruled	out,	various	medical	tests	are	conducted	(e.g.,	for	congenital	
anomalies)	to	exclude	other	possibilities	(Morice	et	al.,	2004).	Once	all	medical	options	have	
been	exhausted,	the	cough	is	considered	refractory	and	more	extreme	steps	are	taken.	Current	
treatments	to	alleviate	RCC	include	medications	such	as	opiates	and	dextromorphan,	the	
effects	of	which	are	controversial	and	have	many	side	effects	such	as	drowsiness,	constipation,	
or	addiction	(Spina	&	Page,	2013).	Morice	and	colleagues	(2007)	conducted	a	randomized,	
double-blind,	placebo-controlled	trial	involving	27	participants	with	RCC	to	study	the	effects	of	
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morphine	on	RCC.	They	found	significant	improvement	in	Leicester	Cough	Questionnaire	(LCQ)	4	
scores	and	in	cough	severity	and	frequency	as	reported	in	a	daily	cough	diary.	However,	there	
was	no	notable	reduction	in	peripheral	laryngeal	hypersensitivity	(tested	via	the	citric	acid	
cough	challenge).	This	result	may	support	the	hypothesis	that	RCC	involves	cortical	control,	as	
morphine	can	also	be	used	to	alleviate	central	(i.e.,	cortical)	neuropathic	pain	(Attal	et	al.,	
2010).	
Emerging	research	also	indicates	that	gabapentin	may	alleviate	symptoms	of	cough;	
however	this	medication	does	not	have	long-standing	effects	(Ryan	&	Gibson,	2014).	In	2001,	
Ryan,	Birring,	and	Gibson	conducted	a	randomized,	double-blind	trial	to	test	the	effects	of	
gabapentin	against	a	placebo.	In	their	study,	26	of	the	64	participants	received	the	gabapentin	
treatment.	The	authors	found	significant	improvements	in	cough	frequency	and	severity	and	in	
overall	LCQ	scores.	However,	all	aforementioned	scores	returned	to	baseline	after	stopping	
gabapentin.	Gabapentin,	therefore,	only	worked	while	patients	were	actively	taking	the	
medication.	The	return	to	baseline,	when	off	of	gabapentin,	suggests	that	gabapentin	affects	
the	central	control	of	the	cough,	but	does	not	affect	the	peripheral	cough	reflex	sensitivity	
(Ryan,	Birring,	&	Gibson,	2012).	
When	controlling	common	aggravating	factors	of	cough	with	medication	fails,	referrals	
may	be	made	to	a	pulmonologist,	a	gastroenterologist,	an	allergist	(Natt	et	al.,	2012),	or	a	
psychologist	(Vertigan	et	al.,	2007a).	A	referral	for	behavioral	cough	therapy	(BCT)	by	a	SLP	
often	occurs	at	the	very	end	of	the	management	algorithm	for	“difficult-to-treat	cough”	along	
																																																						
4	The	LCQ	is	a	validated	survey	with	which	patients	rate	how	their	cough	impacts	their	QoL	
across	physical,	psychological,	and	social	domains	(Brignall	et	al.,	2008,	Pavord	&	Chung,	2008).	
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with	more	extreme	medications	such	as	gabapentin	(Gibson	&	Vertigan,	2009;	McGarvey,	
2013).	McGarvey	(2013)	proposed	an	algorithm	for	“difficult-to-treat	cough”	(see	Figure	2).	
However,	his	proposed	algorithm	places	speech	and	language	intervention	(i.e.,	BCT)	as	a	
consideration	for	only	after	everything	else	has	failed.	Given	that	BCT	is	safe,	affordable,	and	
patients	respond	in	just	a	few	weeks,	consideration	of	BCT	much	earlier	in	the	management	
process	could	save	many	patients	considerable	time	and	money.	
	
Figure	2	Management	algorithm	for	"difficult	to	treat"	cough.	Reprinted	from	McGarvey,	2013	
In	addition	to	saving	time	and	money,	there	are	a	variety	of	reasons	why	RCC	should	be	
treated	with	BCT	provided	by	SLPs.	SLPs	have	knowledge	in	the	areas	of	swallowing,	voice,	and	
motor	speech	disorders	that	equip	them	to	identify	irregularities	in	the	larynx	or	respiratory	
system	(Vertigan	et	al.,	2007).	Furthermore,	RCC	is	often	mitigated	following	the	treatment	of	
comorbid	voice	issues,	like	PVFM,	which	is	commonly	treated	by	SLPs	(Gibson	&	Vertigan,	
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2009).	Finally,	because	similarities	exist	between	medical	conditions	(e.g.	asthma	or	reflux),	
voice	concerns	(e.g.,	hoarseness	or	muscle	tension	dysphonia),	and	psychological	issues	(e.g.,	
depression	or	anxiety)	of	RCC	and	PVFM	(Vertigan	et	al.,	2007),	their	underlying	mechanisms	
are	thought	to	overlap	under	the	umbrella	of	laryngeal	dysfunction	(Ryan,	Vertigan,	&	Gibson,	
2009).	Therefore,	SLPs	can	treat	RCC	with	BCT	efficiently	and	economically	by	targeting	the	
underlying	cause	of	the	cough,	not	just	the	symptoms	(Vertigan	et	al.,	2007).	
Behavioral	Cough	Therapy.	There	are	four	recommended	components	of	a	behavioral	
cough	therapy	(BCT)	program:	education,	cough	suppression,	vocal	hygiene,	and	counseling	
(Vertigan	et	al.,	2006).	These	four	components	are	described	below.	
Education.	First,	the	clinician	educates	the	client	about	the	neurology	behind	cough/	
laryngeal	sensitivity	and	why	cough	suppression	reduces	laryngeal	hypersensitivity.	The	
negative	consequences	of	chronic	cough,	such	as	laryngeal	trauma	and	perpetuating	the	cough	
cycle	are	discussed.	Moreover,	the	patient	is	informed	that	there	are	no	negative	consequences	
for	suppressing	the	cough.	The	education	component	also	plays	an	important	role	for	
promoting	patient	compliance	in	controlling	aggravating	factors	to	cough	(e.g.,	reflux)	
pharmacologically	(Vertigan	et	al.,	2007a).		
Cough	suppression.	In	the	second	component,	the	client	learns	specific	cough	
suppression	techniques.	One	technique	is	relaxed	throat	breathing.	During	relaxed	throat	
breathing,	the	patient	inhales	abdominally	while	focusing	on	a	relaxed	throat.	Then	the	patient	
exhales	while	making	an	“s”	sound.	The	restriction	produced	by	the	“s”	sound	promotes	an	
abducted	airway	(Gibson	&	Vertigan,	2009).	This	technique	is	also	used	in	the	treatment	of	
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paradoxical	vocal	fold	motion	(PVFM).	Other	cough	suppression	techniques	include	substitution	
techniques	(e.g.,	swallowing	instead	of	coughing)	or	distraction	techniques	(e.g.,	chewing	gum).	
The	client	also	identifies	triggers	when	provided	a	list	of	commonly	reported	triggers.	
Frequently	reported	triggers	reported	by	Vertigan	et	al.	(2007a)	include	inhaled	stimuli	(e.g.	
perfumes,	cleaning	agents,	smoke),	temperature	changes	(e.g.,	air	conditioning),	intrinsic	
causes	(e.g.,	anxiety),	or	activity	(e.g.,	exercising	or	talking).		Once	the	patient	identifies	his/her	
triggers,	he/she	can	implement	cough	suppression	strategies	in	their	presence.	
Vocal	hygiene.	The	third	component	involves	vocal	hygiene	techniques	to	improve	any	
habits	that	have	a	drying	effect	on	the	larynx.	The	first	step	is	to	improve	hydration.	Research	
indicates	that	adequate	hydration	can	reduce	the	effort	needed	to	phonate,	which	reduces	the	
possibility	of	laryngeal	injury	(Vertigan	et	al.,	2006).		Other	components	of	vocal	hygiene	
include	avoiding	smoking,	reducing	alcohol	and	caffeine	consumption	which	dehydrate	
laryngeal	tissues,	and	encouraging	nose	breathing	to	reduce	laryngeal	sensitivity	by	humidifying	
the	air	before	approaching	the	larynx	(Gibson	&	Vertigan,	2009;	Vertigan	et	al.,	2006,	Vertigan	
et	al.,	2007a).	
Counseling.	Finally,	the	fourth	component	comprises	counseling	to	promote	motivation	
and	internalization	of	controlling	the	cough.	Internalizing	the	locus	of	control	allows	the	patient	
to	have	power	over	their	cough.	However,	the	clinician	must	validate	the	patient’s	perception	
that	the	cough	is	real	(Vertigan	et	al.,	2007a).	The	process	of	validation	and	internalization	
promotes	compliance	with	controlling	the	cough.	Furthermore,	counseling	supports	setting	
attainable	goals	so	that	BCT	is	successful	(Chamberlain	et	al,	2013;	Gibson	&	Vertigan,	2009;	
Vertigan	et	al.,	2007a).			
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Efficacy	of	BCT.	A	review	of	the	literature	generally	supports	the	effectiveness	of	BCT.	
To	date,	there	is	one	randomized	control	trial	(Vertigan	et	al.,	2006)	and	several	non-
comparative	studies	to	support	the	use	of	BCT	for	RCC	(Murry	et	al.,	2010,	Patel	et	al.,	2011;	
Ryan	et	al.,	2010;	Ryan	et	al.,	2009).	See	Table	1	for	a	summary	of	BCT	studies.	Each	study	
measured	effects	in	various	areas	including	cough	frequency,	cough	severity,	cough	sensitivity,	
and	quality	of	life	(QoL)	(Chamberlain	et	al.,	2014).	For	example,	Ryan	and	colleagues	(2010)	
studied	17	adults	before,	during,	and	after	BCT.	This	was	the	first	study	to	objectively	measure	
BCT’s	effect	on	cough	severity	and	frequency.	They	found	that	after	BCT,	patients	had	reduced	
cough	reflex	sensitivity,	decreased	cough	frequency,	and	improved	laryngeal	symptoms.	Their	
findings	support	the	previous	hypotheses	that	controlling	the	underlying	mechanism	of	cough	
as	well	as	reduced	sensitivity	of	the	cough	receptors	contribute	to	the	success	of	BCT	(Vertigan	
et	al.,	2007a).			Furthermore,	research	behind	cough	suppression	indicates	that	because	
voluntary	cough	is	initiated	in	the	cortex,	it	likely	can	also	be	suppressed	from	within	the	cortex	
(Vertigan	et	al.,	2008).	BCT	suppresses	the	cough	by	increasing	the	strength	of	a	patient’s	
volitional	control	of	the	cough	(Vertigan	et	al.,	2007a).			
Table	1		
Improvement	areas	of	BCT	 	
Intervention	area	 Citation(s)	
Cough	frequency	 Vertigan	et	al.,	2006;	Patel	et	al.,	2011;	Ryan	et	al.,	2010	
	
Cough	severity	 Vertigan	et	al.,	2006;	Murry	et	al.,	2010	
	
Cough	sensitivity	 Ryan	et	al.,	2010;	Ryan	et	al.,	2009	
	
QoL	 Vertigan	et	al.,	2006;	Patel	et	al.,	2011;	Ryan	et	al.,	2010;	Ryan	et	al.,	2009	
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Additionally,	the	current	management	approach	to	managing	RCC	has	detrimental	
effects	on	QoL.	Patel	et	al.	(2011),	Ryan	et	al.	(2009),	and	Ryan	et	al.	(2010)	all	used	the	LCQ	
pre-	and	post-treatment	to	measure	QoL.	In	the	research,	the	minimal	important	difference	for	
the	total	score	of	the	LCQ	is	1.3	(Patel	et	al.,	2011).	That	is,	if	a	patient’s	score	changes	by	at	
least	1.3	points	between	pre-	and	post-treatment,	it	is	considered	significant.	These	three	
studies	found	significant	improvements	in	self-reported	QoL	post-treatment.	Furthermore,	
Patel	et	al.	(2011)	reported	the	improvements	in	each	individual	domain	(i.e.,	physical,	
psychological,	and	social)	of	the	LCQ,	regardless	of	duration	of	the	cough.	Finally,	Vertigan	et	al.	
(2006)	measured	QoL	in	their	study	by	assessing	limitations	in	daily	activities.	They	found	
significantly	reduced	limitations	in	daily	life	in	the	treatment	group	when	compared	to	the	
placebo	treatment.		
Finally,	BCT	is	efficient	and	cost-effective.	While	medical	testing	for	cough	can	take	
months	or	years	to	complete,	BCT	can	be	effective	in	as	few	as	two	sessions	(Chamberlain	et	al.,	
2013,	Gibson	&	Vertigan,	2009;	Ryan	et	al.,	2010;	Vertigan	et	al.,	2007a;	Vertigan	et	al.,	2007).	
For	example,	Vertigan	et	al.	(2006)	conducted	a	randomized,	single-blind,	placebo-controlled	
study	on	BCT.	In	only	four,	30-minute	sessions,	38	out	of	43	subjects	who	received	treatment	
were	considered	successful.	Conversely,	35	out	of	44	in	the	placebo	group	were	considered	
unsuccessful.	Thus,	BCT	should	be	considered	earlier	in	the	management	algorithm	to	mitigate	
the	limiting	effects	of	the	current	framework.	
VARIABLES	ASSOCIATED	WITH	THE	SUCCESS	OF	BCT	 18	
Limitations	of	the	current	cough	management	algorithm.	The	aforementioned	studies	
have	shown	BCT	or	cough-suppression	therapy	to	be	a	non-invasive	and	effective	treatment	for	
RCC	and	they	highlight	the	limitations	in	the	current	“test	all,	then	treat”	approach	to	managing	
CC/RCC	(Iyer	&	Lim,	2013).	For	example,	in	a	retrospective	study,	Murry	et	al.	(2010)	found	that	
patients	reported	that	a	proton-pump	inhibitor	(PPI)	regimen	alone	to	control	reflux	resulted	in	
no	subjective	improvement	in	cough	status.	However,	the	PPI	regimen	in	addition	to	respiratory	
retraining	showed	improvements	in	the	areas	of	sensation	and	cough	reduction.	They	
measured	reflux	symptoms	using	the	Reflux	Symptom	Index,	which	is	a	reliable,	patient-
reported	assessment	of	reflux	symptoms.	They	further	assessed	the	presence	of	laryngeal	
sensitivity	by	applying	pulses	of	air	to	the	back	of	the	throat	and	measuring	the	response.	All	
measures	improved	significantly.	Therefore,	a	simple,	quick,	and	non-invasive	respiratory	
retraining	in	addition	to	a	reflux	control	regimen	might	resolve	the	cough	and	bypass	the	need	
for	extensive	testing.		
	 Another	major	limitation	in	the	research	is	how	many	resources	the	current	
management	algorithm	for	cough	consumes	(see	Figure	1).	As	the	algorithm	demonstrates,	the	
steps	to	exclude	diagnoses	is	extensive	and	requires	many	referrals	and	testing,	which	is	time-
consuming	and	expensive.	Furthermore,	time	and	money	spent	with	referrals	in	testing	is	time	
and	money	lost	because	of	absenteeism	and	lost	productivity	(Iyer	&	Lim,	2013).	Finally,	
behavioral	intervention	is	only	considered	alongside	or	after	invasive	tests	and	potent	drugs	
such	as	morphine	(Iyer	&	Lim,	2013).			
In	summary,	the	current	management	algorithm	for	CC	is	time-consuming	and	
expensive	for	patient	with	RCC.		BCT	is	an	evidence-based	treatment	option	that	is	non-
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invasive,	efficient,	and	inexpensive;	yet,	BCT	is	currently	only	considered	after	all	medical	tests	
and	treatment	options	have	failed	(Iyer	&	Lim,	2013).	The	current	study	addressed	potentially	
altering	the	current	management	algorithm	for	RCC	by	aiming	to	identify	differentiating	
variables	of	patients	that	are	likely	to	be	successful	with	BCT	versus	those	are	not	earlier	in	the	
process.	As	the	sub-set	of	a	larger	ongoing	study,	the	ultimate	goal	is	to	create	a	screening	tool	
for	primary	care	physicians	to	use	in	their	referral	making	process	for	patients	with	chronic	
cough	based	on	their	self-reported	variables.	
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Chapter	2:	Methodology	
Introduction	
The	University	of	Montana	IRB	approved	this	exploratory,	prospective	pilot	study	on	
March	05,	2015.	The	study	was	conducted	in	collaboration	with	an	allergist	and	a	SLP	at	the	
Western	Montana	Clinic,	a	pulmonologist	at	Community	Medical	Center,	and	an	
otolaryngologist	at	Rocky	Mountain	Ear,	Nose	and	Throat	to	investigate	patient-reported	
variables	of	patients	suffering	from	RCC.	The	primary	goal	of	this	study	was	to	determine	if	a	
pattern	of	patient-reported	variables	exist	to	help	differentiate	patients	who	will	benefit	from	
BCT	from	those	who	will	not.	Data	collection	commenced	from	June	2015	to	February	2016.	
Setting	and	Participants	
	 All	data	were	collected	via	Qualtrics	survey	software.	Participants	enrolled	in	the	study	
at	the	offices	of	the	Western	Montana	Clinic,	University	of	Montana	(UM)	Voice	and	Swallow	
Clinic,	Community	Physician	Group,	and	Rocky	Mountain	Ear,	Nose,	and	Throat	in	Missoula,	
Montana.	Subsequent	data	were	collected	on	the	participant's	home	computer	or	over	the	
phone	with	the	researcher.		
Inclusion	criteria	included:	
• at	least	18	years	of	age,	
• complaint	of	a	cough	lasting	at	least	8	weeks	
Exclusion	criteria	included:	
• smoking	for	longer	than	12	months	duration	in	the	past	10	years,	
• 	diagnosis	of	COPD,	lung	cancer,	chronic	bronchitis,	or	emphysema,	and	
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• use	of	an	ACE-inhibitor	medication	within	the	past	two	months.	
	
If	the	participants	met	the	criteria,	they	were	given	an	iPad	and	headphones	containing	
written	and	video	information	describing	the	purpose	and	procedures	of	the	study.	If	the	
participant	consented,	he/she	also	provided	contact	information	for	follow-up.	
Procedures	
Survey	Development.	For	the	development	of	this	survey,	an	interdisciplinary	expert	
panel	consisting	of	an	allergist,	a	pulmonologist,	an	ENT,	and	two	speech-language	pathologists	
(SLPs)	was	assembled.	Each	panelist	was	familiar	with	the	research	on	laryngeal	
sensitivity/chronic	cough	and	regularly	treated	patients	with	RCC.	The	purpose	of	this	panel	was	
to	compile	a	list	of	potentially	relevant	survey	items	based	on	the	cough/	laryngeal	sensitivity	
literature	in	addition	to	professional	experience.		
Having	an	interdisciplinary	panel	also	helped	incorporate	the	various	aspects	of	creating	
a	good	questionnaire.	According	to	Salkind	(2009),	there	are	basic	assumptions,	question	types,	
and	basic	formatting	concerns	that	make	a	quality	survey.	Basic	assumptions	include:	asking	
questions	that	the	target	population	can	answer,	making	the	questionnaire	engaging,	and	being	
direct	and	honest	with	the	information.	The	types	of	questions	asked	should	be	answerable,	
straightforward,	and	socially	appropriate	to	answer.	Finally,	in	formatting	the	questionnaire,	it	
should	be	easy	to	read,	simple,	and	have	guiding	instructions.	In	order	to	achieve	the	basic	
components	of	a	good	questionnaire,	the	survey	for	patients	with	RCC	was	developed	in	stages.		
First,	the	lead	investigator	provided	survey	items	to	the	panel	based	on	the	literature	
and	clinical	experience.	These	proposed	items	included	questions	about	environmental	triggers	
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(e.g.,	strong	perfume),	aggravating	factors	(e.g.,	reflux	or	post-nasal	drip),	and	symptoms	(e.g.,	
feeling	a	“tickle”	in	the	throat	before	coughing).	Second,	each	expert	panelist	added	proposed	
items	based	on	their	knowledge	of	the	research,	their	clinical	experiences,	and	their	specialty	
area.	Proposed	survey	items	were	then	compiled	into	a	Qualtrics	survey	and	distributed	to	each	
expert	panelist.	Expert	panelists	then	rated	the	importance	of	each	potential	item	using	a	four-
point	Likert	scale,	one	being	not	relevant	and	four	being	highly	relevant.	An	average	of	scores	
was	calculated	and	questions	receiving	a	score	of	less	than	two	were	removed	because	they	
were	deemed	to	be	too	general	or	insensitive	to	the	target	population.		
After	finalizing	the	items	for	the	enrollment	questionnaire,	all	components	of	the	survey	
were	organized	into	three	parts:	(1)	the	expert-panel	questions,	(2)	the	Leicester	Cough	
Questionnaire	(LCQ),	and	(3)	a	treatment	and	compliance	portion	(i.e.,	medical	or	behavioral),	
and	cough	status.	Part	one	of	the	survey	provided	detailed	written	consent	and	video	
instructions	to	inform	the	participants	of	the	purpose	and	procedures	of	the	study,	followed	by	
the	option	to	agree	and	continue,	or	disagree	and	exit	the	survey.	Participants	who	agreed	to	
continue	provided	their	contact	information	and	preference	of	contact	method	for	follow-up.	
Part	one	concluded	with	the	questions	created	and	agreed	upon	by	the	expert	panel.	Each	
question	was	rated	using	a	7-point	Likert	scale	in	which	1	signified	all	of	the	time	and	7	signified	
none	of	the	time.	Some	questions	also	included	a	not	applicable	option.	Additionally,	the	expert	
panel	included	questions	allowing	for	multiple	answers	(i.e.,	Q53:	self-perceived	personality	
traits	Q51:	triggers),	previous	or	current	interventions	(i.e.,	Q78-Q84),	and	yes/no	questions	as	
indicated	(i.e.,	Q48-Q49).		See	Appendix	C.		
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	Part	two	of	the	survey	contained	the	Leicester	Cough	Questionnaire	(LCQ),	which	is	a	
validated,	self-report,	7-point	Likert-scale	questionnaire	used	to	assess	cough	and	its	impact	on	
QoL	(Birring	et	al.,	2003;	Brignall	et	al.,	2008).	The	Likert	scale	used	in	part	one	of	the	survey	
was	identical	to	the	Likert	scale	used	in	the	LCQ.		The	LCQ	was	used	to	measure	progress	of	
cough	remediation	in	each	follow-up	contact,	as	explained	in	survey	administration.	(See	
Appendix	D	for	copy	of	the	LCQ.)	Finally,	part	three	of	the	survey	contained	questions	about	
type(s)	of	treatment	(i.e.,	medical	or	behavioral	strategies)	the	patient	had	tried	and	their	
compliance	with	each	treatment.	(See	Appendix	C	for	a	copy	of	the	survey	in	its	entirety.)	
Once	the	items	were	established,	the	survey	was	piloted	with	two	unfamiliar,	healthy	
individuals	to	review	clarity	of	the	written	and	video	instructions,	the	questions,	and	the	flow	of	
the	survey	itself.	Minor	modifications	were	made	to	the	survey	per	the	recommendations	of	
these	individuals.	Once	the	survey	was	finalized,	four	iPads	were	programmed	with	the	survey.		
One	iPad	was	then	delivered	to	each	participating	office	and	the	staff	was	trained	on	how	to	
use	the	iPad	and	to	administer,	reset,	and	avoid	duplicates	of	the	survey.	The	researcher	
assured	that	the	following	basic	training	points	were	covered	at	each	office:	the	purpose	of	the	
study,	inclusion/exclusion	criteria,	and	ultimate	goal	of	the	larger,	ongoing	study.	The	training	
also	included	navigating	the	Qualtrics	survey	software	application	and	assurance	that	Qualtrics	
is	HIPAA	compliant	in	order	to	protect	the	sensitive	information	of	the	participants.		
Survey	administration.	Staff	at	each	participating	office	identified	appropriate	potential	
participants	based	on	a	primary	complaint	of	cough	and	if	they	met	the	inclusion	criteria	of	the	
survey.	If	they	met	the	criteria,	the	staff	then	provided	patients	the	option	to	participate	in	the	
study.	The	staff	provided	the	iPad	and	headphones	in	addition	to	any	technical	support	
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participants	needed	(e.g.,	navigating	the	iPad	or	reading	questions	aloud	for	participants	with	
visual	impairment).	Once	a	participant	declined	to	participate	or	completed	the	survey,	the	staff	
ensured	that	the	survey	had	closed	and	returned	the	program	to	the	informed	consent	and	
instruction	page.	If	the	subject	declined	to	participate,	they	were	exited	from	the	survey.	
However,	if	the	subject	chose	to	participate,	they	completed	parts	one,	two,	and	three	of	the	
survey	(see	Appendices	C-E).		All	participants	completed	the	survey	before	or	immediately	after	
their	first	session	of	BCT.		
Once	patients	were	enrolled	in	the	study,	they	began	BCT,	which	included:	vocal	
hygiene,	education,	cough	suppression	techniques,	and	counseling.		The	two	SLPs	participating	
in	the	study	had	discussed	and	agreed	upon	a	similar	course	of	treatment	before	the	study	
began.	Both	SLPs	provided	the	four	components	of	BCT	(education,	cough	suppression,	vocal	
hygiene,	and	counseling)	in	a	similar	manner	and	with	similar	terminology.		
Following	enrollment,	participants	were	contacted	by	phone,	text,	and/or	e-mail,	
depending	on	their	indicated	preference,	every	three	to	four	weeks	to	monitor	success	of	
treatment(s).	The	follow-up	timeline	was	flexible	due	to	the	nature	of	BCT	and	medical	
treatments	of	cough.	These	treatments	are	not	duration	dependent,	they	either	work	or	they	
do	not.	Therefore,	whether	a	follow-up	was	conducted	at	three	weeks	post-treatment	or	four	
weeks	post-treatment,	the	results	should	not	have	differed.	Parts	two	(the	LCQ)	and	three	
(intervention	type,	compliance,	and	cough	status)	of	the	survey	comprised	the	portion	used	to	
collect	information	at	follow-up	(see	Appendices	D	and	E).	Patients	indicated	which	strategies	
they	had	attempted,	how	compliant	they	had	been	with	the	strategies,	and	whether	they	were	
satisfied	with	the	current	status	of	their	cough.	These	data	also	were	gathered	through	a	
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Qualtrics	survey.	Follow-up	data	continued	to	be	gathered	every	three	to	four	weeks	until	the	
participants	indicated	they	were	content	with	the	status	of	their	cough	or	until	they	no	longer	
wished	to	participate	in	the	study.		
Data	Analysis	
	 Data	analysis	was	performed	by	exporting	the	data	from	Qualtrics	and	uploading	it	into	
the	Statistical	Package	for	the	Social	Sciences	(SPSS)	software.	In	SPSS,	participants	were	coded	
by	group	for	analysis.	Participants	were	grouped	into	one	of	three	groups	based	on	self-
reported	cough	status:	(1)	satisfied	with	BCT	(BCT-S),	(2)	not	satisfied	with	BCT	(BCT-NS),	or	(3)	
unresolved	(participants	who	had	not	yet	had	BCT).	Participants	coded	as	unresolved	were	
excluded	from	analysis.	Participants	who	started	but	did	not	complete	the	survey	were	also	
excluded	from	analysis.	Once	the	groups	were	divided	and	coded,	histograms,	box	plots,	and	
line	graphs	were	created	to	examine	the	distribution	of	each	variable	and	to	obtain	a	primary	
sense	of	which	variables	might	be	significant.		The	Mann-Whitney	U	and	Fisher’s	exact	tests	
were	used	for	variables	with	non-normal	distributions.		The	independent	t-test	was	used	for	
normally	distributed	variables.	Descriptive	statistics	were	also	run.	
	A	Mann-Whitney	U	test	was	used	to	determine	between-group	differences	in	the	Likert	
scale	questions	in	part	one	of	the	survey.	A	Fisher’s	exact	test	was	used	to	look	for	differences	
between	the	groups	regarding	specific	triggers,	allergens,	and	personality	traits5.	Independent	
t-tests	analyzed	change	in	QoL	related	to	cough	from	pre-BCT	and	post-BCT	results	of	the	LCQ.	
The	LCQ	in	turn	served	as	an	outcome	measure	that	was	associated	with	the	patient’s	report	of	
																																																						
5	These	questions	did	not	follow	the	Likert	scale	format.	Rather,	they	were	a	“check	all	that	apply”	format.	Results	
from	these	analyses	investigated	the	patterns	among	patient-reported	variables	in	the	study-specific	portion	of	the	
survey.	
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being	BCT-satisfied	(BCT-S)	or	BCT	not-satisfied	(BCT-NS).	Finally,	being	that	this	study	was	a	
small	subset	of	a	larger	study	aiming	to	create	a	screening	tool	for	patients	with	chronic	cough,	
this	study	only	looked	at	the	self-reported	variables	of	patients	who	underwent	BCT.		 	
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Chapter	3:	Results	
Descriptive	Statistics		
Thirty	eight	participants	enrolled	in	the	study.	Three	participants	dropped	the	study	
before	completion	and	15	are	ongoing	with	follow-up	surveys	as	part	of	a	larger	ongoing	study.	
Twenty	participants	completed	the	study	and	were	included	in	this	analysis.	Out	of	the	20	who	
completed	the	survey,	twelve	reported	being	satisfied	with	BCT	(i.e.,	BCT-S	group)	and	eight	
reported	being	not	satisfied	(i.e.,	BCT-NS	group).	The	participants	in	the	BCT-S	group	(10	
female,	2	male)	had	a	mean	age	of	53.3	years	with	an	average	cough	duration	of	45	months.	
The	participants	in	the	BCT-NS	group	(7	females,	1	male)	had	a	mean	age	of	54.7	years	with	an	
average	cough	duration	of	41	months.	Cough	duration	was	missing	for	two	of	the	participants	
(one	in	each	group)	because	of	a	researcher	oversight	on	the	original	version	of	the	survey.	See	
Table	2	for	a	summary	of	the	descriptive	statistics.		
Table	2.	Descriptive	statistics	of	participants	
	 BCT-S		
	
	 BCT-NS	
	
	 Min	 Max	 Mean	 SD	 	 Min	 Max	 Mean	 SD	
Age	(years)	 29	 67	 53.3	 12.72	 	 46	 68	 57.14	 11.05	
Cough	duration	
(months)	
3.0	 180.0	 45.27	 57.84	 	 3.0	 108.0	 41.0	 43.61	
	
Inferential	Statistics	
Differences	in	patient-reported	variables.	A	Mann-Whitney	U	test	was	performed	to	
analyze	differences	between	the	groups	on	each	Likert	scale	survey	question.	As	seen	in	Table	3	
and	Figure	3,	seven	variables	reached	statistical	significance	(i.e.,	p	≤	.05)	and	four	variables	
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approached	significance	(i.e.,	p	=.051	-	.08).	The	BCT-S	group	reported	more	difficulty	breathing	
in	than	out	(U	=	24,	z	=	-1.891,	p	=	.0295,	r	=0.423),	less	need	to	clear	their	throat	(U	=	20.5,	z	=	-
2.180,	p	=	.0145,	r	=0.487),	a	less	productive	cough	(U	=	26,	z	=	-1.791,	p	=	.0365,	r	=	.40),	more	
reflux/heartburn	(U	=	11,	z	=	-2.914,	p	=	.002,	r	=0.652),	more	difficulty	breathing	in	general	(U	=	
29,	z	=	-1.495,	p	=	.0675,	r	=0.334),	and	more	of	a	sensation	of	pushing	on	their	chest	(U	=	28,	z	=	
-1.622,	p	=	.0525,	r	=0.363)	The	BCT-NS	group	reported	more	of	a	blocked	throat	feeling	(U	=	27,	
z	=	-1.658,	p	=	.0485,	r	=0.061),	more	anxiety	(U	=	24,	z	=	-1.880,	p	=	.03,	r	=0.420),	more	stress	in	
their	neck	and	shoulders	(U	=	15,	z	=	-2.628,	p	=	.0045,	r	=0.588),	more	temporary	alleviation	of	
their	cough	with	sips	of	water	(U	=	28.5,	z	=	-1.529,	p	=	.063,	r	=0.342),	and	more	of	a	concern	
about	pollutant/chemical	exposure	(U	=	30,	z	=	-1.426,	p	=	.077,	r	=0.319).	Mean	scores,	Mann-
Whitney	U	scores,	Z-scores,	p-values,	and	effect	sizes	for	each	variable	are	summarized	in	Table	
3.	Mean	scores	of	significant	or	nearly	significant	variables	are	depicted	in	Figure	3.	Accordance	
with	the	Likert	scale	of	1=all	of	the	time	and	7=none	of	the	time,	a	higher	mean	is	correlated	
with	less	severity.	
Table	3.	Mann-Whitney	U	scores,	mean	score,	Z-scores,	significance	levels,	and	effect	sizes	of	
patient-reported	variables	as	determined	by	Mann-Whitney	U	test	
Variable	 Mean	
BCT-S	
Mean		
BCT-NS	
U	 z-score	 P-value	
(1-tailed)	
Effect	
size	
Q15_Tickle/itch	 3.0	 3.0	 47	 -0.08	 0.468	 0.018	
Q16_	Anticipation	 2.5	 2.35	 36.5	 -0.927	 0.177	 0.207	
Q17_	Sleep	 4.083	 3.95	 39.5	 -0.671	 0.251	 0.150	
Q18_	Suppression	 4.333	 4.55	 37.5	 -0.863	 0.194	 0.193	
Q19_	Water	alleviates	cough**	 4.417	 3.95	 28.5	 -1.529	 0.063	 0.342	
Q20_	Cough	is	productive*	 5.333	 4.7	 26	 -1.791	 0.036	 0.400	
Q21_No	air	 5.0	 5.0	 43	 -0.397	 0.345	 0.089	
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Q22_	Pass	out	 5.833	 6.1	 40.5	 -0.656	 0.256	 0.147	
Q23_	Urge	to	throat	clear*	 4.167	 3.45	 20.5	 -2.18	 0.014	 0.487	
Q24_	Feeling	of	a	blocked	throat*	 5.167	 4.65	 27	 -1.658	 0.048	 0.371	
Q25_	Feeling	of	a	tight	throat	 4.417	 4.5	 44.5	 -0.274	 0.392	 0.061	
Q26_	Pushing	sensation	in	chest**	 4.667	 5.3	 28	 -1.622	 0.053	 0.363	
Q27_	Pushing	sensation	in	throat	 4.25	 4.5	 39	 -0.705	 0.241	 0.158	
Q28_	Difficulty	breathing	in	
general**	 4.167	 4.8	 29	 -1.495	 0.068	 0.334	
Q29_	Inhaler	relieves	breathing	
difficulty	immediately	 5.583	 5.95	 34	 -1.126	 0.13	 0.252	
Q30_	Difficulty	breathing	in*	 4.083	 4.85	 24	 -1.891	 0.029	 0.423	
Q31_	Difficulty	breathing	out	 5.5	 5.75	 35.5	 -0.98	 0.164	 0.219	
Q32_	Tight	chest	w/	symptoms	 4.333	 4.55	 40	 -0.629	 0.265	 0.141	
Q33_	Tight	throat	w/	symptoms	 3.417	 3.65	 33	 -1.177	 0.119	 0.263	
Q34_	Squeaky	inhalation	 5.5	 5.7	 38.5	 -0.754	 0.226	 				0.169	
Q35_	Voice	Problems	 4.0	 4.3	 35	 -1.022	 0.154	 0.229	
Q36_	Voice	Unpredictability	 3.5	 4.1	 36	 -0.946	 0.172	 0.212	
Q37_	GERD/LPR*	 3.25	 4.3	 11	 -2.914	 0.002	 0.652	
Q38_	PND	 3.083	 3.25	 45	 -0.238	 0.406	 0.053	
Q39_	Pollutant/	chemical	
exposure**	 5.583	 5.1	 30	 -1.426	 0.077	 0.319	
Q40_	Feeling	stressed	 3.833	 3.45	 32.5	 -1.217	 0.112	 0.272	
Q41_	Feeling	anxious*	 4.667	 4	 24	 -1.88	 0.03	 0.420	
Q42_	Having	stress/anxiety	w/	
symptoms	 4.667	 4.6	 46.5	 -0.118	 0.453	 0.026	
Q43_	Feeling	lump	in	the	throat	 4.083	 4.2	 44	 -0.317	 0.376	 0.071	
Q44_	Perfume	triggering	
symptoms	 5.0	 5.05	 46.5	 -0.118	 0.453	 0.026	
Q45_	Need	for	control	 3.273	 3.263	 44	 0	 0.5	 0	
Q46_	Anxiety	w/o	control	 4.167	 4.2	 47.5	 -0.039	 0.485	 0.009	
Q47_	Carrying	stress	in	
neck/shoulders*	 3.167	 2	 15	 -2.628	 0.005	 0.588	
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Q48_	Cough	started	with	
illness***	
1.417	 1.4	 46	
-0.182	 0.428	 				0.041	
Q49_	Allergies	make	symptoms	
worse***	 1.333	 1.35	 46	 -0.187	 0.426	 0.042	
	 	 	 	 	 	 	
*=	significant	(p	<	.05)	
**=	approached	significance	(p=	.051-.080)	
***Yes/no	questions:	1=	Yes;	2=	No	
	
Figure	3.	Means	of	significant/nearly	significant	differences	in	variables	as	determined	by	the	
Mann-Whitney	U	test	
*Significant	at	alpha	level	=	.05	
**Approached	significance	at	alpha	level=-051-.080	
Note:	Means	based	on	Likert	scale	1=all	of	the	time	and	7=none	of	the	time	
The	LCQ	was	used	as	a	pre-	and	post-test	measure	of	cough’s	impact	on	quality	of	life.	
There	were	some	significant	or	nearly	significant	differences	in	pre-	and	post-treatment	scores	
in	patients	who	reported	satisfaction	with	BCT	and	no	significant	differences	in	patients	who	
were	not	satisfied.	Recall	an	increase	in	scores	indicates	improvement	in	QoL.	The	BCT-S	
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patients	showed	improvements	in	all	of	the	domains	as	well	as	total	score	while	BCT-NS	
patients	showed	improvements	only	in	the	physical	domain	(see	Figures	4a,	4b).		
	
	
Figure	4a.	Pre-	and	post-treatment	LCQ	scores	for	BCT-S	patients		
*=significant	p<.05		
**=approached	significance	p=.051-.080	
	
	 	
Figure	4b.	Pre-	and	post-treatment	LCQ	scores	for	BCT	unsatisfied	patients	
*=significant	p<.05		
**=approached	significance	p=.051-.080	
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Fisher’s	exact	test	was	used	to	analyze	between-group	differences	for	each	cough	
trigger,	allergen,	and	personality	trait.	No	significant	between-group	differences	were	found	for	
triggers,	allergens,	or	personality	traits.	Tables	4a,	4b,	and	4c	summarize	these	results.		
Table	4a.	Reported	cough	triggers	and	their	significance	between	BCT-S	and	BCT-NS	groups	as	
determined	by	the	Fisher’s	Exact	test.	
	 BCT-S	
(n=12)	
BCT-NS	
(n=8)	
p-value	
(1-tailed)	
Trigger	 No	 Yes	 No	 Yes	 	
Strong	smells	 6	 6	 4	 4	 .675	
Smoke	 8	 4	 4	 4	 .388	
Change	in	air	
temperature	
9	 3	 7	 1	 .465	
Laughing	 10	 2	 5	 3	 .296	
Talking	 12	 0	 6	 2	 .147	
Stress/anxiety	 10	 2	 6	 2	 .535	
Exercise	 5	 7	 6	 2	 .157	
	
Table	4b.	Reported	allergens	and	their	significance	between	BCT-S	and	BCT-NS	groups	as	determined	
by	the	Fisher’s	Exact	test.	
	 BCT-S	
(n=12)	
BCT-NS	
(n=8)	
p-value	
(2-tailed)	
Allergen	 No	 Yes	 No	 Yes	 	
Pollens	 2	 10	 3	 5	 .592	
Animals	 9	 3	 5	 3	 .91	
Molds	 8	 4	 7	 1	 .614	
Foods	 11	 1	 6	 2	 .688	
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Table	4c.	Reported	personality	traits	and	their	significance	between	BCT-S	and	BCT-NS	groups	as	
determined	by	the	Fisher’s	Exact	test.	
	 BCT-S	
(n=12)	
BCT-NS	
(n=8)	
p-value	
(2-tailed)	
Personality	trait	 No	 Yes	 No	 Yes	 	
High-achieving	 7	 5	 2	 6	 .314	
Self-critical	 5	 7	 2	 6	 .784	
Anxious	 10	 2	 4	 4	 .274	
Stressed	 5	 7	 1	 7	 .374	
Worrier	 8	 4	 3	 5	 .41	
Easygoing		 7	 5	 8	 0	 .102	
High-strung	 10	 2	 7	 1	 1.312	
Cooperative	 4	 8	 4	 4	 .776	
Pessimistic	 11	 1	 6	 2	 .688	
Optimistic	 4	 8	 3	 5	 1.216	
Self-motivated	 3	 9	 2	 6	 1.386	
Perfectionist	 6	 6	 3	 5	 .93	
Competitive	 7	 5	 4	 4	 1.07	
Team-oriented	 6	 6	 3	 5	 .93	
Procrastinator	 7	 5	 6	 2	 .784	
Type	A	 11	 1	 5	 3	 .306	
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Chapter	4:	Discussion	
The	purpose	of	this	study	was	to	determine	if	there	are	differences	in	patient-reported	
symptoms	and	other	variables	in	individuals	with	chronic	cough	who	are	successfully	treated	
with	BCT	versus	those	who	are	not	successfully	treated	with	BCT.	To	answer	our	research	
questions,	participants	took	a	survey	assembled	to	determine	different	patient	reported	
variables,	assess	the	cough’s	impact	on	QoL,	and	rate	compliance	with	attempted	strategies.		
Participants	then	completed	BCT	with	a	SLP.	Following	enrollment,	participants	were	contacted	
every	three	to	four	weeks	to	monitor	success	of	treatment.	Participants	completed	the	study	
when	they	had	indicated	that	they	either	were	satisfied	with	their	cough	status	or	continued	to	
be	unsatisfied	after	attempting	BCT	strategies	for	three	to	four	weeks.	Participants	were	then	
filtered	into	either	the	BCT-S	or	BCT-NS	group.	Data	was	analyzed	using	non-parametric	tests	
and	descriptive	statistics	to	determine	patterns	among	patient-reported	variables.	
Research	Question	1:	Is	there	a	difference	in	patient-reported	variables	in	patients	with	RCC	
who	are	satisfied	with	BCT	and	patients	with	RCC	who	are	not	satisfied	with	BCT?	
	 Significant	differences	were	found	in	patient-reported	variables	in	patients	in	the	BCT-S	
group	and	the	BCT-NS	group.	Out	of	the	34	variables	on	the	study-specific	survey,	11	were	
found	to	be	significantly	different.	Based	on	these	results,	we	can	reject	the	null	hypothesis	and	
retain	the	alternative	hypothesis.		
Research	Question	2:	If	differences	are	evident	between	patients	with	RCC	who	are	satisfied	
with	BCT	and	those	who	are	not,	what	variables	will	be	different?			
	 The	following	variables	were	hypothesized	to	be	significantly	different	between	the	two	
groups.		
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	 The	BCT-S	group	will	report	more	difficulty	breathing	in	than	out.	Patients	in	the	BCT-S	
group	reported	having	significantly	more	difficulty	breathing	in	than	out.	This	result	confirms	
the	hypothesis	and	is	consistent	with	the	literature	as	patients	with	RCC	often	have	co-
occurring	PVFM,	which	results	in	more	difficulty	breathing	in	than	out.	Conversely,	patients	
whose	CC	is	caused	by	asthma	tend	to	report	more	difficulty	breathing	out	than	in.		
	 The	BCT-S	group	will	report	a	less	or	non-productive	cough.	Patients	in	the	BCT-S	group	
reported	having	a	less	or	non-productive	cough.	This	result	confirms	the	hypothesis	and	is	
consistent	with	the	literature	as	a	refractory	cough	is	often	described	as	being	a	dry	cough.	
Conversely,	patients	suffering	from	a	lung	pathology	(e.g.,	pneumonia)	would	be	more	likely	to	
report	a	productive	cough.		
	 The	BCT-S	group	will	report	more	of	a	tickling/itching	feeling	in	their	throat.	There	
were	no	significant	differences	between	groups	in	the	report	of	having	a	tickling/itching	feeling	
in	the	throat.	Generally,	the	research	on	RCC	reports	a	tickle	or	itch	that	suggests	a	
hypersensitization	of	the	laryngeal	cells.	However,	the	current	study	did	not	support	this	
common	symptom.		
	 The	BCT-S	group	will	report	the	onset	of	their	cough	began	with	an	illness	that	
involved	significant	coughing.	There	were	no	significant	differences	between	groups	regarding	
onset	of	cough.	It	is	possible	that	CC	and	RCC	in	general	can	be	caused	and/or	exacerbated	by	a	
cold.Significant	coughing	has	been	thought	to	cause	the	hypersensitization	of	the	laryngeal	cells	
based	on	the	principle	of	neuroplasticity	“repetition	matters”	(Kleim	&	Jones,	2008).	The	lack	of	
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significant	difference	in	this	study	may	have	been	due	to	the	small	sample	size.	It	may	be	
worthwhile	to	explore	onset	of	cough	more	in	future	studies.	
	 The	BCT-S	group	will	report	a	higher	occurrence	of	the	following	triggers:	strong	
smells,	changes	in	air	temperature,	exercise,	stress/anxiety,	and	smoke.	There	were	no	
significant	differences	between	groups	regarding	triggers.	However,	one	trigger,	exercise,	
yielded	the	largest	difference	between	groups	as	seven	in	the	BCT-S	group	reported	exercise	as	
a	trigger	but	only	two	in	the	BCT-NS	group	identified	it	as	a	trigger.	This	difference	is	interesting	
because	PVFM	commonly	co-occurs	with	RCC	and	is	often	triggered	by	competitive	sports	
(Giminez	&	Zafra,	2011).		
Based	on	clinical	experience	and	the	literature,	the	lack	of	significant	differences	
regarding	triggers	was	surprising.	There	are	several	potential	reasons	for	this	finding,	the	most	
obvious	being	the	small	sample	size.	Additionally,	the	binary	yes/no	question	format	may	not	
have	been	sensitive	enough	to	detect	differences.	Using	a	similar	Likert	scale	as	was	used	on	
the	other	questions	may	have	been	more	sensitive,	as	it	would	have	captured	severity	of	
triggers.	One	other	possibility	is	that	the	question	regarding	triggers	was	omitted	from	the	
original	survey	for	the	first	24	participants	as	an	accidental	oversight.	The	data	gathered	
regarding	triggers	for	these	patients	was	collected	retrospectively	from	the	initial	cough	
evaluation	performed	by	the	treating	SLP.	As	the	triggers	for	these	patients	were	recorded	from	
interviewing	the	patients	and	not	from	a	visual	list	of	options,	it	is	possible	that	some	triggers	
went	unreported.	Additionally,	it	is	possible	that	patients	did	not	initially	report	all	of	their	
triggers,	due	to	lack	of	awareness.	In	the	author’s	clinical	experience,	some	patients	only	
identify	triggers	after	in-depth	interviewing	or	after	being	asked	to	journal	their	triggers	and	
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thus	possibly	did	not	identify	all	triggers	on	the	survey.	Finally,	another	possibility	for	the	lack	of	
differences	is	that	that	patients	with	any	form	of	chronic	cough	(e.g.,	CC	controlled	by	
medicine)	might	experience	the	same	cough	triggers.		
The	BCT-S	group	will	report	more	“Type	A”	personality	qualities	(e.g.,	high-achieving,	
competitive,	stressed,	need	to	be	in	control,	etc.).	There	were	no	significant	findings	between	
groups	regarding	self-reported	personality	traits.	A	review	of	the	literature	suggested	that	the	
BCT-S	population	might	be	more	anxious,	but	the	results	of	this	study	did	not	support	that	
hypothesis.	It	is	possible	that	self-perception	of	personality	traits	is	not	reliable	and	self-report	
may	not	be	the	most	informative	source	of	this	data.	For	example,	some	participants	may	not	
consider	themselves	to	be	anxious	or	competitive	even	if	others	would	describe	them	as	such,	
and	thereby	may	not	indicate	those	personality	traits	on	the	survey.	Gosling,	John,	Craik,	and	
Robins	(1998),	found	that	the	perception	of	personality	traits	in	oneself	were	distorted	to	be	
more	positive	than	when	rated	by	observers.	Therefore,	if	patients	perceived	being	anxious	or	
needing	to	be	in	control	as	negative,	they	may	not	have	selected	it	as	a	personality	trait.	As	
such,	in	future	studies	it	may	be	interesting	to	have	friends	and/or	family	rate	personality	traits	
of	to	determine	if	there	is	a	difference	in	participants’	perception	and	the	perception	of	others.	
Furthermore,	similar	to	the	trigger	question,	personality	questions	were	also	binary	(e.g.,	
yes/no),	which	may	not	have	been	sufficiently	sensitive	to	capture	differences	between	the	
groups.		In	hindsight,	it	would	have	been	better	to	ask	participants	to	rate	personality	traits	in	a	
Likert	scale	format,	to	capture	gradations	in	personality	characteristics.	.		
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The	following	patient-reported	variables	were	not	accounted	for	in	the	hypotheses,	yet	
yielded	significant	differences	between	the	BCT-S	and	BCT-NS	groups.	Several	of	the	findings	
were	opposite	in	direction	that	anticipated	given	clinical	experience	and	the	literature.		
The	BCT-S	group	reported	more	difficulty	breathing	in	general.	Similar	to	the	BCT-S	
group	reporting	more	difficulty	breathing	in,	they	also	reported	more	difficulty	breathing	in	
general.	It	is	likely	that	participants	who	reported	difficulty	breathing	in	also	reported	more	
difficulty	breathing	in	general,	which	makes	this	finding	not	surprising.		
The	BCT-S	group	reported	a	lower	urge	to	throat	clear.	Throat	clearing	is	a	frequently	
reported	symptom	in	patients	with	RCC,	which	was	not	supported	by	our	findings.	It	is	possible	
that	wording	the	question	has	having	an	“urge”	to	throat	clear	was	less	sensitive	than	if	the	
question	had	been	worded	as	“I	clear	my	throat	frequently	throughout	the	day.”	Additionally,	
clinical	observation	suggests	that	patients	do	not	always	realize	that	they	clear	their	throat	
frequently.		It	is	also	possible	that	the	BCT-NS	group	produced	more	phlegm,	consistent	with	
having	a	more	productive	cough	than	the	BCT-S	group,	which	could	have	resulted	in	the	urge	to	
throat	clear	more	often.	
The	BCT-S	group	reported	more	perceived	reflux/heartburn.	The	question	of	having	
perceived	reflux/heartburn	might	be	worth	exploring	more	in	depth.	It	is	likely	that	patients	
who	were	referred	to	BCT	had	already	been	put	on	medication	to	control	for	the	possibility	of	
acid	reflux,	but	more	frequently	reported	BCT	satisfaction.	Further	investigation	of	this	finding	
is	warranted.	
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The	BCT-S	group	reported	more	sensation	of	something	pushing	on	their	chest.	Given	
that	patients	with	asthma	commonly	report	symptoms	in	the	chest	(which	is	typically	controlled	
with	medicine)	while	patients	with	PVFM	(which	commonly	co-occurs	with	RCC)	more	
commonly	report	symptoms	in	the	throat,	this	was	a	very	surprising	finding.	It	is	possible	that	
the	chest	sensation	could	be	related	to	increased	perception	of	heartburn/reflux.	Further	
investigation	of	this	finding	is	warranted.		
The	BCT-NS	group	reported	more	of	a	blocked	throat	feeling.	This	result	is	not	
consistent	with	the	RCC	literature.	Although	we	had	not	hypothesized	that	the	RCC	group	
would	have	more	of	a	blocked	throat	feeling,	people	with	RCC	often	report	paresthesia,	or	
abnormal	feelings,	in	their	throat.	Therefore,	the	BCT-NS	group	reporting	a	significant	
difference	in	the	blocked	throat	feeling	was	unexpected.	Further	investigation	of	this	finding	is	
warranted	
The	BCT-NS	group	reported	being	more	anxious.	This	result	was	the	opposite	of	what	
we	had	expected	because	patients	anxiety	has	been	associated	with	some	common	voice	
disorders,	such	as	PVFM	or	MTD	(Gimenez	&	Zafra,	2011;	Vertigan	et	al.,	2008).	Furthermore,	
anxiety	is	common	cough	trigger	throughout	the	RCC	literature.	It	may	be	that	patients	in	the	
BCT-NS	group	had	a	more	severe	cough,	which	contributed	to	worse	anxiety.	.			
The	BCT-NS	group	reported	having	more	stress	in	their	neck/shoulders.	This	finding	
was	also	opposite	of	what	we	would	have	expected.	Because	muscle	tension	dysphonia	(MTD)	
commonly	co-occurs	with	RCC,	and	patients	with	MTD	tend	to	carry	stress	in	their	
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neck/shoulders,	we	anticipated	that	the	BCT-S	group	would	be	more	inclined	to	carry	stress	in	
their	neck/shoulders..		
The	BCT-NS	group	reported	more	cough	alleviation	with	drinking	water.	The	BCT-NS	
group	also	reported	more	tickling/itching	in	their	throat,	as	well	as	more	phlegm	production.	It	
is	possible	that	water	was	more	likely	to	alleviate	these	sensations,	which	would	also	help	
alleviate	cough.		.		
The	BCT-NS	group	reported	more	concern	of	chemical/pollutant	exposure.	The	expert	
panel	included	this	question	based	on	clinical	experience	that	many	patients	with	PVFM,	which	
commonly	co-occurs	with	RCC,	worry	about	past	chemical/pollutant	exposure.	It	was,	
therefore,	surprising	that	the	BCT-NS	group	reported	a	greater	concern	in	this	regard.	The	
finding	could	be	related	to	severity	of	cough.		If	the	BCT-NS	group	had	a	more	severe	cough,	
they	may	have	had	a	greater	concern	about	pollutant/chemical	exposure.		
Leicester	Cough	Questionnaire:	Pre-	and	Post-BCT	
Consistent	with	our	expectations,	there	were	significant	differences	in	pre-	and	post-
treatment	LCQ	scores	in	the	BCT-S	group.	Three	of	the	four	domain	scores	were	at	or	
approached	significance.		While	the	physical	domain	did	not	meet	the	level	of	significance,	it	is	
likely	that	it	would	have	reached	significance	in	a	larger	sample	size.	It	is	interesting	that	the	
BCT-S	group	had	more	significant	QoL	improvements	in	the	social	and	psychological	domains,	
while	the	BCT-NS	group	had	more	significant	QoL	improvements	in	the	physical	domain	
(although	not	statistically	significant).	These	results	suggest	that	the	success	of	BCT	alleviated	
the	social	(e.g.,	interfering	with	daily	tasks	or	enjoyment	of	life)	and	psychological	(e.g.,	feeling	
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frustrated,	worried,	or	anxious)	components	of	cough	more	so	than	the	physical	components	of	
cough.	To	see	all	of	the	questions	that	fall	under	which	domain,	see	the	color-coded	version	of	
the	LCQ	in	Appendix	D,	Part	IIb.	 		
Limitations	
	There	are	several	limitations	of	this	study.	First,	the	number	of	participants	that	
completed	all	of	the	criteria	was	only	20.	Furthermore,	there	was	an	uneven	number	between	
the	groups,	twelve	in	the	satisfied	group	and	eight	in	the	unsatisfied	group.	This	uneven	
number	was	likely	partially	based	on	the	binary	response	of	being	satisfied	or	not	satisfied	that	
did	not	capture	cough	severity.	Additionally,	the	study	lacked	an	objective	cough	severity	
measure,	such	as	a	capsaicin	challenge.	It	depended	wholly	on	subjective	patient	report	which	
may	have	resulted	in	inaccurate	results.	For	example	patients	in	the	BCT-NS	group	reported	
improvements,	but	may	have	not	improved	enough	to	feel	satisfied.	An	objective	measure	
could	have	captured	the	physiological	improvement	of	cough.		
Another	limitation	of	this	study	was	the	manner	in	which	some	of	the	questions	were	
asked.	First,	some	of	the	questions	were	redundant	and/or	unclear.	For	example,	there	was	one	
question	of	“I	have	difficulty	breathing”	and	then	two	other	questions	of	“When	I	have	difficulty	
breathing,	it	is	hardest	to	breathe	in.”	and	“When	I	have	difficulty	breathing,	it	is	hardest	to	
breathe	out.”	This	creates	an	overlap	of	questioning	and	may	inflate	the	significance	of	the	
answers	as	two	questions	account	for	the	same	symptom.	Second,	there	were	questions	that	
might	have	been	more	sensitive	if	written	in	a	different	format.	For	example,	we	did	not	use	the	
Likert	scale	for	triggers,	allergens,	and	personality	traits.	Rather,	participants	were	given	a	
binary	“yes”	or	“no”	choice	for	each	trigger/allergen/personality	characteristic.		Asking	the	
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participants	to	rate	the	severity	level	of	each	item,	including	a	“not	applicable”	option,	likely	
would	have	been	more	sensitive.		
Patient	recruitment	and	subsequent	participant	demographics	posed	another	limitation.	
It	would	have	been	interesting	to	recruit	participants	earlier	in	the	treatment	process	for	CC	in	
order	to	include	data	from	participants	whose	cough	resolved	with	medicine	alone.	This	was	
the	original	intent	of	the	study;	however,	recruitment	from	the	physicians’	offices	was	minimal,	
so	the	focus	of	analysis	was	narrowed	only	to	include	patients	who	were	referred	for	BCT.	
Recruitment	from	physicians’	offices	likely	could	have	been	better	if	the	instructions	and	
purpose	of	the	study	had	been	made	clearer	during	their	initial	training.	Two	of	the	
participating	physicians	express	that	they	thought	we	were	only	looking	for	patients	who	would	
also	participate	in	BCT	and	thus	it	was	assumed	the	SLP	receiving	the	referral	could	enroll	the	
participant	in	the	study.		
Finally,	there	was	a	limitation	regarding	patient	compliance.	It	is	likely	that	patients	with	
poor	compliance	also	had	low	“buy	in”	to	perform	the	behavioral	strategies	of	BCT.	If	a	patient	
does	not	believe	that	an	intervention	will	work,	it	is	doubtful	that	the	patient	will	maintain	
compliance.	Patient’s	compliance	may	also	have	been	negatively	impacted	because	of	minimal	
external	motivation	to	maintain	their	performance	of	the	BCT	strategies,	as	the	two	SLPs	often	
saw	each	participant	only	twice:	the	initial	evaluation	and	one	follow-up.	Furthermore,	some	of	
the	patients	declined	to	schedule	a	follow-up	appointment.	It	might	have	been	interesting	to	
analyze	the	participants	who	did	and	did	not	schedule	a	follow-up	appointment	against	their	
self-reported	level	of	compliance.		Furthermore,	investigating	why	certain	people	did	not	
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schedule	a	follow-up	appointment	may	have	revealed	areas	for	improvement	within	BCT,	such	
as	providing	more	thorough	education	on	how	CC	and	laryngeal	hypersensitivity	work.	
Future	directions	
There	are	several	proposed	considerations	for	future	research	on	this	topic.	First,	the	
results	indicate	it	may	be	possible	to	create	a	screening	tool	based	on	patient-reported	
variables	to	differentiate	patients	who	may	benefit	from	an	early	referral	to	BCT.	In	order	to	
create	such	a	tool,	future	studies	will	need	a	larger	number	of	participants.	Specifically,	future	
studies	should	recruit	more	participants	who	are	either	not	successful	with	BCT,	or	do	not	need	
BCT	because	they	are	successfully	treated	with	medicine.	Future	studies	should	include	
recruitment	of	participants	from	physicians	who	regularly	and	successfully	treat	patients	with	
CC	in	order	to	compare	patients	whose	cough	resolves	with	medicine	to	those	whose	cough	
resolves	following	BCT.	Data	from	that	comparison	will	further	differentiate	patient-reported	
variables	that	predict	success	with	BCT.	It	may	also	be	beneficial	to	base	group	assignment	on	
an	objective	measure	of	cough	status,	such	response	to	known	cough	stimulants	such	as	
capsaicin	or	citric-acid.	Additionally,	a	larger	number	of	participants	will	allow	for	the	use	of	
parametric	statistical	measures	such	as	linear	regression,	discriminant	analysis,	or	factor	
analysis	to	determine	which	items	are	predictive	of	BCT	success.		The	data	from	this	preliminary	
pilot	study	will	contribute	to	estimating	the	necessary	sample	size	for	the	ongoing	larger	study	
that	is	already	in	process	with	these	goals	in	mind.		
Future	studies	may	also	want	to	consider	creating	domains	for	measurement,	similar	to	
the	LCQ,	by	grouping	questions	based	on	theory	or	analyzing	features	of	the	patient-reported	
variables.	For	example,	there	could	be	a	“throat	sensations”	domain	that	would	include:	feeling	
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a	tickle/itch	in	their	throat	(Q15),	frequently	clearing	the	throat	(Q23),	having	a	blocked	feeling	
in	the	throat	(Q24),	having	a	tight	feeling	in	the	throat	(Q25),	having	a	pushing	sensation	on	the	
throat	(Q27),	having	a	tight	throat	when	experiencing	cough	symptoms	(Q33),	and	feeling	like	
there	is	a	lump	in	the	throat	(Q43).	One	possibility	for	determining	how	to	cluster	questions	is	
to	continue	to	cross-examine	this	survey’s	items	with	the	LCQ,	but	also	with	the	Newcastle	
Laryngeal	Hypersensitivity	Questionnaire6,	which	formatted	its	questions	to	align	with	the	LCQ	
(Vertigan,	Bone,	&	Gibson,	2014).	(See	Appendix	F	for	a	copy	of	this	questionnaire.)	
	 Future	studies	should	also	consider	patient	motivation	and	compliance	with	BCT	as	an	
important	focus.	On	one	hand,	it	may	be	worth	investigating	dosage	of	BCT	sessions	and	patient	
compliance.	As	the	SLPs	in	this	study	often	only	conducted	an	initial	and	one	follow-up	session,	
future	studies	may	want	to	research	the	effects	of	two	or	three	follow-up	sessions.	On	the	
other	hand,	it	may	be	worth	incentivizing	participants	treated	at	the	current	dosage	level	to	be	
compliant	and	forthcoming	with	their	level	of	compliance	to	improve	the	likelihood	of	obtaining	
accurate	data.	A	facilitating	option	may	be	an	increased	emphasis	on	the	locus	of	control	that	
participants	have	regarding	BCT	strategies	and	their	cough.	An	important	component	of	BCT	is	
that	the	person	takes	control	of	their	cough	through	implementation	of	cough	suppression	
strategies.	It	is	possible	that	some	people	do	not	make	a	strong	connection	between	
suppression	strategies	and	cough	mitigation,	but	rather	they	conclude	that	their	cough	is	out	of	
their	control	and	that	there	is	no	point	in	attempting	BCT.	Therefore,	promoting	patient	“buy	
in”	for	the	strategies	could	influence	their	locus	of	control	and	subsequently	their	compliance	
																																																						
6	Vertigan	et	al.,	(2014)	created	the	Newcastle	Laryngeal	Hypersensitivity	Questionnaire	to	measure	the	level	of	
laryngeal	dysfunction	across	all	hypersensitivity	syndromes	(RCC,	PVFM,	MTD,	and	globus	pharyngeus,	or	the	
sensation	of	something	being	stuck	in	the	throat).	
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with	strategies.	Obtaining	“buy	in”	with	future	patients	may	be	positively	impacted	by	an	early	
referral	to	BCT,	before	the	participant	is	frustrated	from	exhausting	options,	and/or	by	the	
clinician	providing	a	thorough	education	regarding	the	cause	and	treatment	of	their	cough.	
Future	clinicians	may	also	increase	“buy	in”	and	compliance	by	conducting	an	extensive	initial	
interview	in	order	to	determine	the	patient’s	principle	concerns	and	desired	target	areas	to	
then	create	patient-centered	goals	woven	together	with	BCT	strategies.	Review	of	these	goals	
upon	follow-up	may	be	beneficial	to	reinforce	compliance.		
Clinical	Implications	
	 It	is	currently	not	common	practice	to	refer	patients	with	CC	to	an	SLP	for	BCT	until	the	
cough	is	considered	refractory	and	medical	options	have	been	exhausted	(Gibson	&	Vertigan,	
2009;	McGarvey,	2013).	This	study	provides	pilot	evidence	that	it	may	be	possible	to	create	a	
screening	tool	that	can	differentiate	patients	who	are	likely	to	have	success	with	BCT	from	
those	who	likely	will	not.	Creation	of	a	validated	screening	tool	could	help	patients	be	referred	
for	BCT	early	and	appropriately.	An	early	referral	could	avoid	the	expensive	and	time-
consuming	process	of	exhausting	medical	options	to	alleviate	their	cough.	It	also	could	reduce	
the	cough	duration	that	a	patient	suffers	prior	to	a	BCT	referral,	which	can	take	as	long	as	18-60	
months	(Chamberlain	et	al.,	2013).	This	study	also	contributed	further	evidence	for	the	efficacy	
of	BCT,	as	participants	in	both	the	BCT-S	and	BCT-NS	groups	demonstrated	improvements	on	all	
scores	of	the	LCQ	post-BCT,	indicating	that	BCT	did	help	reduce	cough	severity	in	all	patients.		
Conclusion	
The	current	study	provides	preliminary	evidence	that	suggests	that	there	are	differences	
in	patient-reported	variables	associated	with	success	of	BCT.	These	findings	further	suggest	that	
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there	is	potential	to	create	a	chronic	cough	screening	tool	based	on	self-reported	variables	of	
patients	suffering	from	CC	(see	Appendix	G	for	a	prototype).	This	study	provides	additional	
evidence	for	the	efficacy	of	BCT.	It	is	unique	in	that	it	researches	the	idea	that	patient-reported	
variables	could	discriminate	who	would	likely	benefit	from	BCT.	While	the	data	from	this	study	
are	based	on	a	small	sample	size,	there	are	emerging	significant	differences	that	will	likely	be	
strengthened	with	future,	larger	studies.		As	this	study	is	a	small	sub-set	of	a	larger,	ongoing	
study,	these	results	can	help	guide	future	revisions	to	the	questionnaire	and	surveying	process.	
Eventually,	the	hope	is	that	primary	care	physicians	can	use	such	a	tool	to	refer	patients	early	
and	appropriately	for	medical	or	behavioral	intervention.	Ultimately,	further	research	will	lend	
support	to	the	efficacy	of	BCT	and	the	appropriate	population	to	implement	behavioral	
strategies.		
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Appendix	A	
Informed	Consent		
Q1	Please	click	on	the	arrow	in	the	middle	of	the	video	screen	to	watch	the	following	video:	
Q2				You	are	invited	to	participate	in	a	research	project	about	treatment	for	chronic	
cough.		Please	start	by	answering	the	following	questions.	
Are	you	at	least	18	years	old?																																	
Have	you	had	a	cough	for	at	least	8	weeks?												
If	you	answered	NO	to	questions	1	or	2,	you	do	NOT	qualify	for	the	study.		Please	STOP	and	
return	this	ipad.		If	you	answered	YES	to	questions	1	and	2,	please	continue.						
Do	you	have	a	history	of	smoking	(beyond	just	trying	it	or	smoking	less	than	12	months	over	10	
years	ago)?																																							
Have	you	been	diagnosed	with	any	of	the	following:	COPD,	lung	cancer,	chronic	bronchitis,	
emphysema?																																																			
Have	you	taken	an	ACE-inhibitor	medication	within	the	past	two	months	(e.g.,	
lisinopril/Prinivil/Zestril,	captopril/Capoten,	enalapril/Epaned/Asotec,	ramipril/Altace,	
benazepril/Lotensin,	fosinopril/Monopril,	moexipril/Univasc,	perindopril/Aceon,	
quinapril/Accupril,	trandolapril/Mavik)?					
If	you	answered	YES	to	questions	3,	4,	or	5,	you	do	NOT	qualify	for	the	study.	Please	STOP	and	
return	the	ipad.		If	you	answered	NO	to	questions	3,	4,	and	5,	you	do	qualify	to	participate	in	
the	study.	Please	continue	reading.				
If	you	agree	to	take	part	in	this	study,	you	will	answer	a	brief	online	survey	today	and	every	
three	weeks	until	you	are	satisfied	with	the	treatment	for	your	cough.	Today’s	survey	should	
take	approximately	10	minutes	to	complete.	All	surveys	after	today	should	take	no	more	than	5	
minutes.		Participation	is	voluntary,	and	responses	will	be	kept	confidential.	Qualtrics	survey	
software	is	used	to	administer	the	survey	and	is	encrypted	and	compliant	with	the	Health	
Information	Portability	and	Protection	Act	(HIPPA).	Only	designated	researchers	will	have	
password	protected	access	to	your	data.				
If	you	choose	to	enroll	in	this	study,	the	Principle	Investigator,	Professor	Laurie	Slovarp	(or	a	
research	assistant),	will	contact	you	via	phone	or	email	every	three	weeks.	They	will	provide	
you	with	a	link	to	the	Qualtrics	website	to	fill	out	a	short	survey,	which	should	take	no	more	
than	5	minutes.	If	you	do	not	have	access	to	the	internet,	we	will	fill	out	the	survey	for	you	by	
asking	you	the	questions	over	the	phone,	or	we	can	mail	the	survey	to	you	via	the	US	Postal	
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Service.		We	will	continue	to	collect	data	from	you	every	three	weeks	until	you	are	satisfied	
with	your	cough	treatment.		You	may	also	withdraw	from	the	study	at	any	time.				
Risks/Discomforts				
There	is	no	risk	or	discomfort	associated	with	your	involvement	in	this	study.	Participation	or	
non-participation	will	not	impact	your	relationship	with	The	University	of	Montana	or	your	
physician/clinician.	Entrance	and	submission	of	the	survey	will	be	interpreted	as	your	informed	
consent	to	participate	and	that	you	affirm	that	you	are	at	least	18	years	of	age.				
Benefits				
By	participating	in	this	study,	your	cough	status	will	be	monitored	on	a	regular	basis.	If	you	do	
not	respond	to	treatment,	your	physician	will	be	notified	and	other	treatment	options	may	be	
explored.	Your	participation	in	this	research	also	may	contribute	to	the	knowledge	base	on	how	
best	to	treat	patients	with	chronic	cough.				
If	you	have	any	questions	about	this	research,	please	contact	the	Principal	Investigator,	Laurie	
Slovarp,	via	email	at	laurie.slovarp@umontana.edu	or	phone	at	(406)243-2107.		If	you	have	any	
questions	regarding	your	rights	as	a	research	subject,	contact	the	UM	Institutional	Review	
Board	(IRB)	at	(406)	243-6672.				
Payment				
There	will	be	no	cost	to	you	for	participating	in	this	study	and	you	will	not	receive	payment	for	
participating.				
Confidentiality			
	Your	identity	and	the	information	that	is	obtained	about	you	during	this	study	will	remain	
confidential	to	the	extent	provided	by	law.		However,	National	Institute	of	Health,	The	US	Food	
and	Drug	Administration	(FDA),	study	staff,	study	sponsor,	and	the	University	of	Montana	
Investigational	Review	Board	may	review	your	records	to	verify	study-related	information.		If	
the	study	results	are	published	or	presented,	you	will	not	be	identified	by	your	name.				
Compensation	for	Injury				
Although	there	are	no	foreseen	risks	in	taking	part	in	this	study,	the	following	liability	statement	
is	required	in	all	University	of	Montana	consent	forms:		“In	the	event	that	you	are	injured	as	a	
result	of	this	research	you	should	individually	seek	appropriate	medical	treatment.		If	the	injury	
is	caused	by	the	negligence	of	The	University	or	any	of	its	employees,	you	may	be	entitled	to	
reimbursement	or	compensation	pursuant	to	the	Comprehensive	State	Insurance	Plan	
established	by	the	Department	of	Administration	under	the	authority	of	M.C.A.,	Title	2,	Ch	9.		In	
the	event	of	a	claim	for	such	injury,	further	information	may	be	obtained	from	The	University’s	
Claims	representative	or	University	Legal	Counsel.”	(Reviewed	by	University	Legal	Counsel,	July	
6,	1993)				
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It	is	not	the	regular	policy	of	The	University	of	Montana,	the	sponsor	of	this	research	study,	to	
provide	compensation	for	injury	beyond	what	is	stated	in	the	above	paragraph.		You	still	have	
all	of	your	legal	rights	to	seek	other	compensation.			
Voluntary	Participation/Withdrawal				
Your	decision	to	take	part	in	this	research	study	is	voluntary.	You	may	refuse	to	take	part	in	or	
you	may	withdraw	from	the	study	at	any	time	without	penalty	or	loss	of	benefits	to	which	you	
are	normally	entitled.				
Questions				
This	research	study	has	been	reviewed	by	the	University	of	Montana	Investigational	Review	
Board	(UMIRB)	for	the	purpose	of	protecting	your	safety	and	rights.		The	UMIRB	was	instituted	
under	Federal	and	State	law	to	review	studies	such	as	this	one	in	order	to	protect	research	
participants	from:	unnecessary	risks,	risks	that	outweigh	the	benefits,	procedures	that	are	
scientifically	unnecessary.					
If	you	have	any	questions	regarding	your	rights	as	a	research	study	participant,	you	may	call	the	
UMIRB	Coordinator	at	(406)	243-6672.				
If	you	have	any	questions	about	the	research	procedures	now	or	during	the	study	contact:	
Laurie	Slovarp,	The	University	of	Montana,	Department	of	Communicative	Sciences	and	
Disorders	(CSD	031),	(406)243-2107.						
	
Q3	*	I	have	read	the	above	information.	I	attest	that	I	am	at	least	18		years	of	age.		I	agree	to	
participate	in	this	research	project.Would	you	like	to	participate	in	this	research?	
m Yes	(1)	
m No	(2)	
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Appendix	B	
Demographics	
Q4	Please	enter	your	first	name.	(If	you	are	using	an	ipad,	touch	the	box	with	your	finger	first.	If	
you	are	using	a	computer,	click	on	the	box	with	the	mouse	first.)	
	
Q5	Please	enter	your	last	name.	(If	you	are	using	an	ipad,	touch	the	box	with	your	finger	first.	If	
you	are	using	a	computer,	click	on	the	box	with	the	mouse	first.)	
	
Q6	Please	choose	your	gender.	
m Male	(4)	
m Female	(5)	
m Other	(6)	
	
Q7	Please	enter	your	date	of	birth.	
	
Q8	Please	enter	your	phone	number	including	area	code.	You	may	add	more	than	one	
number.		If	you	do,	please	indicate	which	number	you	prefer.	
	
Q9	Please	enter	your	email	address.	We	promise	we	will	not	send	you	anything	other	than	
information	specific	to	this	study.		We	will	not	give	anyone	your	email	address.		If	you	do	not	
have	an	email	address,	leave	blank.		
	
Q10	Which	form	of	communication	do	you	prefer?	
q Phone	(1)	
q Text	message	(2)	
q Email	(3)	
q Any	of	these	forms	are	fine	(4)	
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Q11	Do	you	have	access	to	the	internet?	(If	you	do	not,	we	will	plan	to	gather	data	with	you	
over	the	phone.)	
m Yes	(1)	
m No	(2)	
	
Q12	Please	enter	how	long	ago	your	cough	started.	
	
Q13	Please	enter	the	professional	that	referred	you	to	this	survey.	
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Appendix	C	
Part	I:	Study	Specific	Survey	
	
Q14	For	each	of	the	following	questions,	click	the	circle	that	best	applies	to	your	symptoms	
within	the	past	week.	
	
Q15	I	feel	a	"tickle"	or	"itch"	in	my	throat	before	I	start	coughing.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q16	I	can	tell	when	I'm	about	to	cough.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q17	I	cough	during	sleep.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
VARIABLES	ASSOCIATED	WITH	THE	SUCCESS	OF	BCT	 60	
Q18	I	am	able	to	suppress	my	cough	for	short	periods	of	time.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q19	Sipping	water	helps	my	cough	for	short	periods	of	time.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q20	My	cough	is	productive	(i.e.,	phlegm	or	mucous	comes	up	when	I	cough).	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q21	I	cough	so	hard	that	I	can't	get	air	into	my	lungs.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
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Q22	I	cough	so	hard	that	I	nearly	pass	out.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q23	I	find	myself	clearing	my	throat	frequently.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q24	My	throat	feels	blocked.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
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Q25	My	throat	feels	tight.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q26	I	have	a	sensation	of	something	pushing	on	my	chest.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q27	I	have	a	sensation	of	something	pushing	on	my	throat.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q28	I	have	difficulty	breathing.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
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Q29	When	I	use	a	rescue	inhaler,	it	works	immediately.	
	 All	of	
the	time	
(1)	
Most	of	
the	time	
(2)	
A	good	
bit	of	
the	time	
(3)	
Some	of	
the	time	
(4)	
A	little	
of	the	
time	(5)	
Hardly	
any	of	
the	time	
(6)	
None	of	
the	time	
(7)	
Not	
applicable	
(8)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q30	When	I	have	difficulty	breathing,	it	is	hardest	to	breathe	in.	
	 All	of	
the	time	
(1)	
Most	of	
the	time	
(2)	
A	good	
bit	of	
the	time	
(3)	
Some	of	
the	time	
(4)	
A	little	
of	the	
time	(5)	
Hardly	
any	of	
the	time	
(6)	
None	of	
the	time	
(7)	
Not	
applicable	
(8)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q31	When	I	have	difficulty	breathing,	it	is	hardest	to	breathe	out.	
	 All	of	
the	time	
(1)	
Most	of	
the	time	
(2)	
A	good	
bit	of	
the	time	
(3)	
Some	of	
the	time	
(4)	
A	little	
of	the	
time	(5)	
Hardly	
any	of	
the	time	
(6)	
None	of	
the	time	
(7)	
Not	
applicable	
(8)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q32	When	I	am	having	my	symptoms,	I	feel	tightness	in	my	chest.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
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Q33	When	I	am	having	my	symptoms,	I	feel	tightness	in	my	throat.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q34	When	I	am	having	trouble	breathing,	I	make	a	squeaky	sound	when	inhaling.	
	 All	of	
the	time	
(1)	
Most	of	
the	time	
(2)	
A	good	
bit	of	
the	time	
(3)	
Some	of	
the	time	
(4)	
A	little	
of	the	
time	(5)	
Hardly	
any	of	
the	time	
(6)	
None	of	
the	time	
(7)	
Not	
applicable	
(8)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q35	I	have	a	problem	with	my	voice.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q36	My	voice	is	unpredictable.	Sometimes	it	is	fine	and	other	times	it	sounds	bad,	but	it	
doesn't	follow	a	predictable	pattern.	
	 All	of	
the	time	
(1)	
Most	of	
the	time	
(2)	
A	good	
bit	of	
the	time	
(3)	
Some	of	
the	time	
(4)	
A	little	
of	the	
time	(5)	
Hardly	
any	of	
the	time	
(6)	
None	of	
the	time	
(7)	
Not	
applicable	
(8)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	 m 	
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Q37	I	think	I	have	reflux/heartburn.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q38	I	think	I	have	post-nasal	drip.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q39	I	am	concerned	about	past	exposures	to	environmental	pollutants/chemicals.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q40	I	feel	stressed.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
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Q41	I	feel	anxious.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q42	When	I	am	stressed	or	anxious,	my	symptoms	are	worse.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q43	I	feel	a	lump	in	my	throat.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q44	My	breathing	shuts	down	when	there	is	someone	in	the	room	with	strong	perfume	and	I	
have	to	leave.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
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Q45	I	feel	the	need	to	be	in	control.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q46	I	feel	anxious	when	I	am	not	in	control.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q47	I	carry	a	lot	of	stress	in	my	neck/shoulders.	
	 All	of	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance.	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q48	My	cough	started	with	an	illness	that	involved	significant	coughing	(e.g.,	cold,	bronchitis,	
whooping	cough,	etc.)	
m Yes	(1)	
m No	(2)	
	
Q49	Do	you	think	environmental	allergies	make	your	symptoms	worse?	
m Yes	(1)	
m No	(2)	
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Q50	What	environmental	allergies	trigger	your	cough/breathing	difficulty?	
q seasonal	pollens	(1)	
q animals	(2)	
q molds	(3)	
q foods	(4)	
q not	applicable,	I	don't	have	environmental	allergies	(5)	
	 	
Q51	Do	any	of	the	following	trigger	coughing	or	difficulty	breathing?	(pick	all	that	apply.)	
q Strong	smells	(e.g.,	perfumes,	cooking,	chemicals)	(1)	
q Smoke	(2)	
q Change	in	air	temperature	(3)	
q Laughing	(4)	
q Talking	(5)	
q Stress/anxiety	(6)	
q Exercise	(7)	
q None	(8)	
q Other	(9)	
Q52	If	other,	please	enter	trigger(s)	here:	
Q53	Check	each	of	the	following	personality	characteristics	that	describe	you.	
q high-achieving	(1)	
q self-critical	(2)	
q anxious	(3)	
q stressed	(4)	
q worrier	(5)	
q laid-back/easy	going	(6)	
q high	strung	(7)	
q cooperative	(8)	
q pessimistic	(9)	
q optimistic	(10)	
q self-motivated	(11)	
q perfectionist	(12)	
q competitive	(13)	
q team	oriented	(14)	
q procrastinator	(15)	
q Type	A	(16)	
Q54	Please	click	"Next"	to	continue.		You	are	more	than	half	way	done.		Thank	you!!!!	
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Appendix	D	
Part	IIa:	Leicester	Cough	Questionnaire	(LCQ)	
Q55	Remember	to	answer	the	following	questions	according	to	how	they	apply	to	you	during	
the	past	week.	
Q56	Check	the	item	that	matches	how	serious	you	feel	your	cough	problem	is	OVERALL.	
m No	problem	(1)	
m Mild	problem	(2)	
m Moderate	problem	(3)	
m Severe	(4)	
	
Q57	Check	the	item	that	matches	how	serious	you	feel	your	cough	problem	is	TODAY.	
m No	problem	(1)	
m Mild	problem	(2)	
m Moderate	problem	(3)	
m Severe	(4)	
	
Q58	Have	you	had	chest	or	stomach	pains	as	a	results	of	your	cough?	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q59	Have	you	been	bothered	by	phlegm	production	when	you	cough?	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
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Q60	Have	you	been	tired	because	of	your	cough?	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q61	Have	you	felt	in	control	of	your	cough?	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q62	Have	you	felt	embarrassed	by	your	coughing?	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q63	My	cough	has	made	me	feel	anxious.	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
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Q64	My	cough	has	interfered	with	my	job,	or	other	daily	tasks.	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q65	My	cough	has	interfered	with	the	overall	enjoyment	of	my	life.	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q66	Exposures	to	paints	or	fumes	has	made	me	cough.	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
	
Q67	Has	your	cough	disturbed	your	sleep?	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
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Q68	How	often	per	day	have	you	had	coughing	bouts?	(in	the	past	week)	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q69	My	cough	has	made	me	feel	frustrated.	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q70	My	cough	has	made	me	feel	fed	up.	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q71	Have	you	suffered	from	a	hoarse	voice	as	a	result	of	your	cough?	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
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Q72	Have	you	had	a	lot	of	energy?	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q73	Have	you	worried	that	your	cough	may	indicate	serious	illness?	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
Q74	Have	you	been	concerned	that	other	people	think	something	is	wrong	with	you,	because	of	
your	cough?	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
	
Q75	My	cough	has	interrupted	conversations	or	telephone	calls.	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
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Q76	I	feel	that	my	cough	has	annoyed	my	partner,	family	or	friends.	
	 All	the	
time	(1)	
Most	of	
the	time	
(2)	
A	good	bit	
of	the	
time	(3)	
Some	of	
the	time	
(4)	
A	little	of	
the	time	
(5)	
Hardly	any	
of	the	
time	(6)	
None	of	
the	time	
(7)	
Choose	
relevance:	
(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
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Part	IIb:	LCQ	with	Color-Coded	Domains	
	
	
	 	 	
All the 
time 
	
Most of 
the time 
	
A good bit 
of time 
	
Some of 
the time 
	
A little of 
the time 
	
Hardly 
any of the 
time 
	
None of 
the time 
	
1 
Have you had chest or stomach pains as a 
result of your cough? 
	
1 
	
2 
	
3 
	
4 
	
5 
	
6 
	
7 
	
2 
Have you been bothered by phlegm 
production when you cough? 
	
1 
	
2 
	
3 
	
4 
	
5 
	
6 
	
7 
	
3 
	
Have you been tired because of your cough? 
	
1 
	
2 
	
3 
	
4 
	
5 
	
6 
	
7 
4 Have you felt in control of your cough? 7 6 5 4 3 2 1 
	
5 
Have you felt embarrassed by your 
coughing? 
	
1 
	
2 
	
3 
	
4 
	
5 
	
6 
	
7 
6 My cough has made me feel anxious. 1 2 3 4 5 6 7 
	
7 
My cough has interfered with my job, or 
other daily tasks. 
	
1 
	
2 
	
3 
	
4 
	
5 
	
6 
	
7 
	
8 
I felt that my cough interfered with the 
overall enjoyment of my life. 
	
1 
	
2 
	
3 
	
4 
	
5 
	
6 
	
7 
	
9 
Exposure to paints or fumes has made me 
cough. 
	
1 
	
2 
	
3 
	
4 
	
5 
	
6 
	
7 
10 Has your cough disturbed your sleep? 1 2 3 4 5 6 7 
	
11 
How many times a day have you had 
coughing bouts? 
	
1 
	
2 
	
3 
	
4 
	
5 
	
6 
	
7 
12 My cough has made me feel frustrated. 1 2 3 4 5 6 7 
13 My cough has made me feel fed up. 1 2 3 4 5 6 7 
	
14 
Have you suffered from a hoarse voice as a 
result of your cough? 
	
1 
	
2 
	
3 
	
4 
	
5 
	
6 
	
7 
15 Have you had a lot of energy? 7 6 5 4 3 2 1 
	
16 
Have you worried that your cough may 
indicate serious illness? 
	
1 
	
2 
	
3 
	
4 
	
5 
	
6 
	
7 
	
17 
Have you been concerned that other people 
think something is wrong with you, 
because of your cough? 
	
1 
	
2 
	
3 
	
4 
	
5 
	
6 
	
7 
	
18 
My cough has interrupted 
conversations or telephone calls. 
	
1 
	
2 
	
3 
	
4 
	
5 
	
6 
	
7 
	
19 
I feel that my cough has annoyed my partner, 
family or friends. 
	
1 
	
2 
	
3 
	
4 
	
5 
	
6 
	
7 
	
For clinician use only: 
( a )    = Physical: 1,2,3,9,10,11,14,15  (b)      = Psychological:  4,5,6,12,13,16,17  (c)      = Social: 7,8,18,19 Domain scores: total score from items in domain/number of items 
in domain  
(range 1 -7).   Total scores: addition of domain scores (range 3-21). 
	
Leicester Cough Questionnaire. © 2001  
 
Physical	Domain	Score:	_____/8			 Psychological	Domain	Score:	_____/7	
	
Social	Domain	Score:	_____/4	 	 	 	 Total:	_____	
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Appendix	E	
Part	III:	Intervention	type,	Compliance,	and	Cough	Status	
	
Q78	Are	you	now	or	have	you	within	that	last	2	weeks	taken	a	prescribed	medication	for	your	
cough	(including	medication	for	post-nasal	drip,	reflux,	sinus	problems)?	
m NO	(1)	
m YES	(2)	
	
Q79	Which	of	the	following	medications	have	you	taken	in	the	past	2	weeks	and	how	long	have	
you	been	taking	each?	(leave	blank	if	not	applicable)	
	 	 	 	 	
Medication	for	
post-nasal	drip	(1)	 q <1	week	(1)	 q 1-2	weeks	(2)	 q 3-4	weeks	(3)	 q >4	weeks	(4)	
Medication	for	
reflux	(2)	 q <1	week	(1)	 q 1-2	weeks	(2)	 q 3-4	weeks	(3)	 q >4	weeks	(4)	
Medication	for	
asthma	(3)	 q <1	week	(1)	 q 1-2	weeks	(2)	 q 3-4	weeks	(3)	 q >4	weeks	(4)	
Sinus	rinse	(4)	 q <1	week	(1)	 q 1-2	weeks	(2)	 q 3-4	weeks	(3)	 q >4	weeks	(4)	
Other	medication	
for	cough	(please	
explain):	(5)	
q <1	week	(1)	 q 1-2	weeks	(2)	 q 3-4	weeks	(3)	 q >	4	weeks	(4)	
	
	
Q80	How	compliant	have	you	been	with	taking	your	medication	as	prescribed?	
	 Not	very	
compliant	(	
Somewhat	
compliant	(50-70%	
of	the	time)	(2)	
Fairly	compliant	
(70-90%	of	the	
time)	(3)	
Very	compliant	
(>90%	of	the	time)	
(4)	
Choose	one	(1)	 m 	 m 	 m 	 m 	
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Q81	On	a	scale	from	1-7,	please	rate	the	effectiveness	of	the	medication	in	the	past	week	in	
regards	to	your	cough.	
	 1	(not	at	
all	
effective)	
(1)	
2	(2)	 3	(3)	 4	(4)	 5	(5)	 6	(6)	 7	
(completely	
effective)	
(7)	
Please	
rate	your	
answer	(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
	
Q82	Are	you	now,	or	have	you	within	the	last	2	weeks,	used	behavioral	strategies	
recommended	by	a	speech-language	pathologist	to	manage	your	cough?	
m NO	(1)	
m YES	(2)	
	
Q83	How	compliant	have	you	been	with	following	the	behavioral	strategies	as	prescribed	by	
your	speech-language	pathologist?	
	 Not	very	
compliant	(	
Somewhat	
compliant	(50-70%	
of	the	time)	(2)	
Fairly	compliant	
(70-90%	of	the	
time)	(3)	
Very	compliant	
(>90%	of	the	time)	
(4)	
Choose	one	(1)	 m 	 m 	 m 	 m 	
	
	
Q84	On	a	scale	from	1-7,	please	rate	the	effectiveness	of	behavioral	cough	strategies	during	the	
past	week.	
	 1	(not	at	
all	
effective)	
(1)	
2	(2)	 3	(3)	 4	(4)	 5	(5)	 6	(6)	 7	
(completely	
effective)	
(7)	
Please	
rate	your	
answer	(1)	
m 	 m 	 m 	 m 	 m 	 m 	 m 	
	
	
VARIABLES	ASSOCIATED	WITH	THE	SUCCESS	OF	BCT	 78	
Q85	Are	you	satisfied	with	your	current	status	in	regards	to	your	cough?	
m NO	(1)	
m YES	(2)	
	
Q86	Do	you	feel	you	need	any	additional	treatment	for	your	cough?	
m NO	(1)	
m YES	(2)	
m I'M	NOT	SURE	(3)	
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Appendix	F	
Newcastle	Laryngeal	Hypersensitivity	Questionnaire		
	
(1=all	of	the	time;	2=most	of	the	time;	3=a	good	bit	of	the	time;	4=some	of	the	time;	5=a	little	
of	the	time;	6=hardly	any	of	the	time;	7=none	of	the	time)	
1.	There	is	an	abnormal	sensation	in	my	throat.	
2.	I	feel	phlegm	and	mucous	in	my	throat.	
3.	I	have	pain	in	my	throat.	
4.	I	have	a	sensation	of	something	stuck	in	my	throat.	
5.	My	throat	is	blocked.	
6.	My	throat	feels	tight.	
7.	There	is	an	irritation	in	my	throat.	
8.	I	have	a	sensation	of	something	pushing	on	my	chest.	
9.	I	have	a	sensation	of	something	pressing	on	my	throat.	
10.	There	is	a	feeling	of	constriction	as	though	needing	to	inhale	a	large	amount	of	air.	
11.	Food	catches	when	I	eat	or	drink.	
12.	There	is	a	tickle	in	my	throat.	
13.	There	is	an	itch	in	my	throat.	
14.	I	have	a	hot	or	burning	sensation	in	my	throat.	
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Appendix	G	
Prototype	of	Refractory	Chronic	Cough	Questionnaire	
	 	 	
All	the	time	
	
Most	of	the	
time	
	
A	good	bit	of	
time	
	
Some	of	
the	time	
	
A	little	of	
the	time	
	
Hardly	 any	
of	the	time	
	
None	of	
the	time	
1	 My	cough	is	productive	
(i.e.,	phlegm	or	mucous	
comes	up	when	I	cough).	
1	 2	 3	 4	 5	 6	 7	
2	 I	find	myself	clearing	my	
throat	frequently.	 1	 2	 3	 4	 5	 6	 7	
3	 Sipping	water	helps	my	
cough	for	short	periods	of	
time.	
1	 2	 3	 4	 5	 6	 7	
4	 My	throat	feels	blocked.	 1	 2	 3	 4	 5	 6	 7	
5	 I	have	a	sensation	of	
something	pushing	on	my	
chest.	
1	 2	 3	 4	 5	 6	 7	
6	 When	I	have	difficulty	
breathing,	it	is	hardest	to	
breathe	in.	
1	 2	 3	 4	 5	 6	 7	
7	 When	I	have	difficulty	
breathing,	it	is	hardest	to	
breathe	out.	
1	 2	 3	 4	 5	 6	 7	
8	 I	think	I	have	
reflyx/heartburn,	 1	 2	 3	 4	 5	 6	 7	
9	 I	think	I	have	post-nasal	
drip.	 1	 2	 3	 4	 5	 6	 7	
10	 I	think	I	have	asthma.	 1	 2	 3	 4	 5	 6	 7	
11	 I	am	concerned	about	past	
exposures	to	
environmental	
pollutants/chemicals.	
1	 2	 3	 4	 5	 6	 7	
12	 I	feel	anxious.	 1	 2	 3	 4	 5	 6	 7	
13	 I	carry	a	lot	of	stress	in	my	
neck/shoulders.	 1	 2	 3	 4	 5	 6	 7	
14	 Strong	smells	(e.g.,	
perfumes,	cleaning	
products)	make	my	
symptoms	worse	and/or	
trigger	my	urge	to	cough.	
1	 2	 3	 4	 5	 6	 7	
15	 Smoke	makes	my	
symptoms	worse	and/or	
triggers	my	urge	to	cough.	
1	 2	 3	 4	 5	 6	 7	
16	 Changes	in	air	
temperature	(e.g.,	walking	
into	an	air	conditioned	
room)	make	my	symptoms	
worse	and/or	trigger	my	
1	 2	 3	 4	 5	 6	 7	
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urge	to	cough.	
17	 Laughing	makes	my	
symptoms	worse	and/or	
triggers	my	urge	to	cough.	
1	 2	 3	 4	 5	 6	 7	
18		 Talking	makes	my	
symptoms	worse	and/or	
triggers	my	urge	to	cough.	
1	 2	 3	 4	 5	 6	 7	
19	 Stress	and/or	anxiety	
make	my	symptoms	worse	
and/or	trigger	my	urge	to	
cough	
1	 2	 3	 4	 5	 6	 7	
20	 Exercise	makes	my	
symptoms	worse	and/or	
triggers	my	urge	to	cough.	
1	 2	 3	 4	 5	 6	 7	
DOMAINS:	 Symptoms	 Parasthesias	 Breathing	 Comorbidities	 Stress/anxiety	 Triggers	
	
